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ABSTRACT 
Background:  
The evaluation of the understanding of medical diseases of the 
kidney which dwells predominantly upon Glomerulopathies, is one of the 
most fascinating stories in the history of Medicine. There is a rising 
incidence of kidney disease and it is responsible for high rate of 
morbidity. Glomerulonephritis constitutes nearly 60% of all non-surgical 
renal diseases and accounts for a substantial number of cases of end stage 
renal disease. End stage renal disease is one of the reasons for increasing 
input of patients in hemodialysis units. 
Aim of the study: 
 To analyse the histomorphology, the extent of involvement of 
GBM using special stains like Periodic acid sciff and Jone’s methanamine 
silver stains and specific immunofluorescence pattern of the renal 
diseases to diagnose and categorize them.  
Materials and methods:  
The study was done for a period of 20 months between October 
2012 and July 2014. A total number of 58 renal biopsies were received 
from the Department of Nephrology, Coimbatore Medical College and 
Hospital, Coimbatore. The biopsy was subjected to light microscopic 
examination and immunofluorescence studies.  
Results: 
A total of 58 renal biopsies were analysed in Coimbatore Medical 
College and Hospital, Coimbatore between October 2012 and July 2014. 
The most common age group affected was between 31 years to 40 years.  
Females (51.72%) were slightly more affected than males (48.27%). Out 
of 58 cases, 46 (79.31%) showed primary glomerular lesions, 10 
(17.24%) showed secondary glomerular lesion and 2 (3.45%) showed 
tubulointerstitial nephritis. Diffuse proliferative glomerulonephritis was 
the most common primary glomerular lesion with a total of 13 out of 58 
cases (22.41%). Lupus nephritis was the most common secondary 
glomerular lesion with a total of 7 out of 58 cases (12.07%). Jones’s 
methanamine silver stain along with PAS stain aided in demonstrating the 
extent of GBM involvement and thereby helped in typing/staging of 
membranous glomerulopathy and membranoproliferative 
glomerulonephritis. Immunofluorescence studies showed positivity in 42 
patients accounting for 72.41%. The predominant pattern was granular 
glomerular basement membrane which was noted in 18 patients 
(31.03%). The diagnostic utility of IF was noted in 4 cases (6.90%) 
whose diagnoses included IgA nephropathy and C1q nephropathy. The IF 
studies helped in modification of the final diagnosis in 1 case (1.72%) 
whose final diagnosis was lupus nephritis class I.  
Conclusion: 
 Immunofluorescence studies have complemented the clinical, 
histomorphological findings in 53 patients both in primary and secondary 
glomerular diseases. However, it was even more of diagnostic importance 
in 5 patients including IgA nephropathy, C1q nephropathy and Lupus 
nephritis class I where a confident diagnosis could be rendered only 
because of availability of immunofluorescence studies. Hence, 
immunofluorescence studies when combined with histomorphologic 
findings by light microscopy, clinical, biochemical and serological 
markers can yield a better and precise diagnosis.  
 
Key words: Renal biopsy, Immunofluorescence, Glomerulonephritis. 
 
 
  
 
 
 
 
 
INTRODUCTION 
1 
 
INTRODUCTION 
The evaluation of the understanding of medical diseases of the 
kidney which dwells predominantly upon glomerulopathies, is one of the 
most fascinating stories in the history of Medicine. There is a rising 
incidence of kidney disease and it is responsible for high rate of 
morbidity.[1] 
Inflammation of the glomerulus is called glomerulonephritis, while 
glomerulopathy is a term used for disorders affecting the glomeruli. 
Glomerulonephritis constitutes nearly 60% of all non-surgical renal 
diseases and accounts for a substantial number of cases of end stage renal 
disease. End stage renal disease is one of the reasons for increasing input 
of patients in hemodialysis units.[1] 
Glomerular lesions evolve over a period of time from active 
inflammatory lesion  into a chronic sclerotic lesion. Information of these 
transitions are necessary for the diagnosis and therapy. Glomerular 
diseases can occur as primary glomerulonephritis or secondary to 
systemic diseases. The immunological basis of glomerular diseases 
involves the deposition of immune complexes in subepithelial, 
subendothelial or in the mesangium. 
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Renal biopsy plays a vital part in establishing the diagnosis, 
prognosis, and response to treatment. Renal biopsies are done to ascertain 
the diagnosis, rule out other diagnostic possibilities, assessing the activity 
and chronicity (scarring) of the lesion. Light microscopy is the standard 
procedure to evaluate kidney biopsies and haematoxylin and eosin stain 
along with special stains like Periodic-acid Schiff, Jone’s methenamine 
silver stain are routinely employed to identify the involvement of the 
basement membrane. Periodic acid Schiff and Jone’s methanamine silver 
stain defines very well glomerular basement membrane and 
Bowman’capsule, and they are the best stain to evaluate the glomerulus.[3] 
Direct immunofluorescence (DIF) on frozen tissue biopsy  is the most 
widely applied method for the detection of immune deposits in the 
kidney.[2] 
The introduction of a safe and reliable percutaneous biopsy method 
by Iver and Brun in 1951 opened the door to the modern classification of 
glomerular diseases. The final diagnosis of renal disease is made possible 
with the interpretation of renal biopsy using light microscopy, 
immunofluorescence studies and electron microscopy.[2,3] 
Light microscopic morphology is assessed by staining the sections 
with standard stains like haematoxylin and eosin and other stains. When 
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light microscopic appearances are equivocal, immunofluorescence studies 
may reveal a pattern which enables the glomerular lesions to be 
identified.[2]  Electron microscopy is expensive and may not be feasible in 
all situations. 
The present study aims to analyse the clinical features in renal 
diseases, histomorphology of renal biopsy, Periodic acid Schiff and 
Jone’s methanamine silver staining to highlight the extent of involvement 
of glomerular basement membrane. Also, specific immunofluorescence 
pattern is studied by applying the panel of immunofluorescent markers 
IgG, IgA, IgM, C3, C1q and fibrinogen. 
Based on the above findings, the etiopathogenesis of renal diseases 
in the patient is analysed and better therapeutic strategies can be 
formulated and administered to improve the clinical  outcome of the 
patient. 
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AIM OF THE STUDY 
To analyse the clinical features, histomorphology and use of 
Periodic acid Schiff and Jone’s methanamine silver staining to highlight 
the extent of involvement of glomerular basement membrane in selective 
cases and to study the  specific immunofluorescence  pattern by applying 
the immunofluorescent markers.  
OBJECTIVES 
1. To analyse the clinical features and parameters in the spectrum of  
renal diseases and to correlate with the histomorphological 
diagnosis.  
2. To correlate histomorphological diagnosis and special stains  
including Periodic acid Schiff and Jone’s methanamine silver 
stains in renal diseases.  
3. To correlate the clinical features and parameters, histomorphology,  
immunofluorescence pattern and special stains in diagnosing and 
categorizing renal diseases.  
 
 
 
  
 
REVIEW OF 
LITERATURE 
 
5 
 
REVIEW OF LITERATURE 
EMBRYOLOGY OF KIDNEY: 
The human kidney arises from two different sources namely the 
metanephros and ureteric bud. The excretory tubules or nephrons are 
derived from metanephros. The collecting part of the kidney is derived 
from the ureteric bud. As the ureteric bud grows cranially towards the 
metanephros, its growing end becomes dilated to form an ampulla. The 
ampulla divides repeatedly. The first three to five generations of branches 
fuse to form the pelvis of the kidney. The next divisions form the major 
calyces and further divisions form the minor calyces and the collecting 
ducts. The cells of metanephros form solid clumps in relation to the 
ampullae. Each solid clump becomes a vesicle and the vesicle becomes 
pear shaped and opens into the ampulla. Its distal end becomes 
invaginated by a tuft of capillaries which form a glomerulus. The kidneys 
are located in the sacral region during embryogenesis and ascends to the 
lumbar region in the subsequent development.[4] 
GROSS ANATOMY: 
The kidney is a paired bean shaped organ measuring 12 cm 
(length), 6 cm (width), and 2.5cm (thickness), and weighing between 120 
and 175 grams.  
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It is covered by a thin fibrous capsule called the renal capsule 
which ends at the renal sinus. Cortical surface of the kidney is covered by 
fat called perirenal fat. Enclosing the perinephric fat is a condensed 
extraperitoneal fascia called as Gerota’s fascia. Each kidney has 8-18 
lobes.[5,7] 
The cut surface of  the kidney shows an outer cortex and an inner 
medulla. The cortex is usually 1cm to 1.2cm thick over the pyramids. The 
medulla consists of renal pyramids whose  apices are called as papillae, 
each of which is connected to a calyx. Cortical tissue  in between two 
adjacent pyramid is called as renal columns of bertini.[5] 
HISTOLOGY: 
One to two million nephrons can be seen in each kidney, which 
forms the structural and the functional element. Each nephron consists of 
a glomerulus, proximal and distal tubules, connecting segment, and the 
collecting duct.[6] 
Renal corpuscle (Fig A) has a Bowman’s capsule and glomerulus. 
The Bowman’s capsule consists of visceral layer called as podocyte and 
the parietal layer. The space in between them is called as Bowman’s 
space. This space continues with the lumen of the renal tubule. The 
glomerulus consist of an intricate branching system of capillaries arising 
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at the afferent arteriole and draining into the efferent arteriole. The entry 
and exit of the arterioles (vascular pole) lies opposite to the entrance of 
the renal tubule (tubular pole).[1,6] 
The glomerulus consists of three types of cells namely mesangial, 
endothelial and epithelial cells. The outer surface of the capillaries is 
lined by the visceral epithelial layer or podocytes. The components of 
glomerular basement membrane are type IV collagen, laminin, 
proteoglycans predominantly heparan sulphate and several other minor 
components like enactin, fibronectin, glycoproteins. The endothelial cells 
are thin which line the inner surface of  the capillaries. The capillary tufts 
are supported by the mesangium which comprises of two components like 
the mesangial cells and the extracellular mesangial matrix.[1,6] 
The proximal tubule, the loop of Henle and distal tubules are lined 
by single layer of cuboidal cells which has microvillous luminal border. 
The tubules are completely surrounded by a basement membrane. 
Adjacent tubular basement membrane are close to each other with little 
intervening connective tissue stroma that contains peritubular 
capillaries.[1,6] 
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HISTOLOGY OF NORMAL GLOMERULUS. 
 
Fig A: showing normocellular glomerulus with patent capillary loops and 
normal thickness basement membrane. 
ELECTRON MICROSCOPY OF THE GLOMERULAR FILTERING 
MECHANISM: 
The capillary endothelium has multiple fenestrae, each being 70 to 
100 nanometer in width. 
The GBM in adults measures approximately about 340 nanometers 
to 360 nanometers and is thicker in males compared to females.  It is a 
trilaminar structure with central thick electron dense layer called lamina 
densa and thinner electron lucent layers on either side which lies beneath 
endothelial and epithelial layers called lamina rara interna and lamina rara 
externa respectively. 
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Each podocyte has a nucleus and cytoplasmic extensions which 
divide and form finger-like extensions that inter-communicate with 
similar structures from neighbouring cells and wrap the capillaries. These 
are known as pedicles or foot processes. The gaps between the foot 
processes is called filtration slits and are bridged by slit diaphragms 
composed of transmembrane protein called nephrin.[1,7,8] 
PATHOGENESIS OF GLOMERULAR INJURY: 
The immune mechanisms underlie most types of glomerular 
diseases. Antibody mediated injury plays the major role and cell mediated 
immunity and other mechanisms also can cause glomerular injury. 
Following are the types of antibody-mediated injury that have been 
recognized: 
1. Glomerular injury caused by deposition of circulating soluble 
antigen-antibody complexes. 
2. Injury within the glomerulus  by antibodies reacting with either 
insoluble fixed native glomerular antigens or with  planted 
molecules in the glomerulus which may be endogenous like DNA, 
nuclear proteins, immunoglobulins, immune complexes formed 
elsewhere in the body or exogenous like drugs, infectious agents. 
3. Antibodies directed  against glomerular cell components. 
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The antigen-antibody complexes that are formed within the 
glomeruli or in the circulation are trapped in the glomeruli, producing 
injury, causing complement activation, leucocyte recruitment and 
proliferation of endothelial, mesangial, and parietal epithelial cells.[1] 
Interaction between immune complexes in-situ and trapped 
circulating complexes, local hemodynamics and structural determinants 
in the glomerulus all contribute to the variety of morphologic and 
functional changes leading to glomerulonephritis.[8] 
The factors affecting the localization of antigen, antibody, or 
immune complexes are the molecular charge and size of the reactants, 
glomerular haemodynamics, mesangial function and the integrity of the 
charge-selective glomerular barrier.[1] 
 Planted antigens reacting with the antibodies tend to deposit in the 
mesansium and give a granular pattern of immunoglobulin deposition and 
antibodies that react against fixed antigens of the glomeruli, for eg; GBM, 
result in the linear deposition along the GBM which can be visualized 
with immunofluorescent microscopy.[1] 
Once immune complexes are deposited in the kidney, they are 
degraded or phagocytosed by the leucocytes and the mesangial cells if the 
antigen exposure is of a short duration. If there is chronic antigen 
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exposure, constant cycles of immnune complexes formation, deposition 
and injury occurs leading to chronic glomerulonephritis like in case of 
hepatitis B virus infection, or systemic lupus erythematosus.[1] 
Antibodies and immune complexes cause injury by complement 
activation, leucocyte recruitment releasing a variety of mediators and 
even sometimes direct podocyte injury. Podocyte injury is reflected by 
flattening of foot processes, cell vacuolization, shrinkage and 
denudement.[1,8,9] 
When there is glomerular filtration rate reduction to almost half of 
normal, end stage kidney disease occurs inevitably. Patients have 
proteinuria with their  kidneys showing sclerosis. Adaptive changes start 
occurring in the remaining glomeruli undergoing  hypertrophy trying to 
maintain renal function. These adaptive changes become maladaptive due 
to disturbances in renal haemodynamics leading to further injury to the 
kidney and progressing to segmental or global sclerosis of the glomeruli. 
A vicious cycle sets in ultimately reducing the nephron mass and leading 
to glomerulosclerosis.[1,8,28] 
NEPHROTIC SYNDROME 
Many primary and secondary glomerulonephritis are associated with 
nephrotic syndrome and it is important to distinguish all of them into 
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different types because of the diverse glomerular lesions, and their 
different clinical outcomes, treatments and prognoses. Furthermore 
differentiating them helps in the development of disease-specific 
therapies.[8]  
The nephrotic syndrome comprises of heavy proteinuria, 
hypoalbunemia, hyperlipidemia and edema. The kidney loses about 80 to 
150 milligram of urinary protein per day in normal adult of which 60% is 
excreted by the glomeruli and remaining portion is secreted by the 
tubules (Tamm-Horsfall protein). Nephrotic range proteinuria is excretion 
of 3.5grams or greater protein per day per 1.73 meter square surface area. 
Addition of tubular protein (Tamm-Horsfall protein), alterations in the 
glomerular permeability and tubular resorption may result in 
proteinuria.[7]  
Recently, altered glomerular permeability has been studied and 
observed that increased glomerular permeability owes to the proteinuria. 
The  characteristic lesions seen in the glomeruli by electron microscopy 
are replacement of the foot process by continuous sheets of flattened 
cytoplasm, reduction in the number of epithelial slits with formation of 
occlusion junction, epithelial vacuolization and focal areas of epithelial 
cell detachment.[8]    
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    The basic defect is urinary protein loss, and the 
hypoalbuminemia, production of edema, and hyperlipidemia stem from it. 
Hypoalbuminemia in the nephrotic syndrome is resulted from the 
combination of increased urinary loss and increased catabolism of 
albumin, chiefly in the kidney. The liver reacts to hypoalbuminemia by 
increasing albumin synthesis, but in the NS the response is inadequate . 
The hypoalbuminemia then leads to both hyperlipidemia and edema 
formation. Hyperlipidemia in NS has many different mechanisms. The 
principle alteration is the higher levels of low density lipoproteins (LDL), 
apolipoprotein B, very low density lipoproteins. Increased levels of 
Apoprotein B leads to both hypoalbulinemia and reduced colloid oncotic 
pressure. Increase in these proteins are because of decreased catabolism 
and not because of increased synthesis. High density lipoproteins (HDL) 
show slight change in their levels so that the LDL/HDL ratio is increased. 
In addition, there is increase in triglycerides and lipoprotein-a levels  by 
synthesis alone.[7,8] 
Underlying mechanism for edema formation is now called as 
underfill hypothesis which states that hypovolemia is the primary 
stimulus for edema formation by driving the kidney to retain sodium and 
water through Starling forces. However, most NS patients are either 
normovolemic or hypervolemic. Thus, overfill hypothesis was developed 
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according to which sodium retention was primary, leading to increased 
blood volume  and increased blood pressure, changing the Starling forces 
thereby causing edema. Several factors result in sodium retention like 
reduced colloid oncotic pressure causing decrease in sodium filtration, 
distal tubular injury causing resistence to atrial natriuretic peptide, 
resulting in decreased natriuresis; chronic tubulointerstitial nephritis 
resulting in reduced GFR and sodium retention. Rostoker et al found that 
steroid therapy resolved abnormal glomerular permeability in patients 
with nephrotic syndrome. They proposed that a cytokine or other vascular 
permeability factor might be responsible for edema formation.[8]   
Conditions associated with nephrotic syndrome are  minimal change 
disease, focal segmental glomerulosclerosis, membranous 
glomerulonephritis, membranoproliferative glomerulonephritis, 
crescentic glomerulonephritis, mesangioproliferative glomerulonephritis 
including IgA nephropathy, congenital and familial nephrotic syndromes, 
amyloidosis, diabetes mellitus, SLE, HSP, drugs, intravenous drug abuse, 
pregnancy, obesity, sarcoidosis, bee stings and infections.[7,8]  
NEPHRITIC SYNDROME 
Nephritic syndrome comprises of hematuria, increased blood urea 
nitrogen and serum creatinine causing uremia, oliguria and mild to 
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moderate hypertension, proteinuria but not in the nephrotic range,  mild 
edema manifested by facial puffiness. Urinalysis shows sediments having 
leucocytes, RBCs and RBC casts.[7]  
Many primary and secondary glomerulonephritis manifest with 
nephritic syndrome. Primary glomerulonephritis presenting with nephritic 
syndrome are IgA nephropathy, acute postinfectious glomerulonephritis, 
crescentic glomerulonephritis, dense deposit disease and secondary 
glomerulonephritis like lupus nephritis, HSP, mixed connective tissue 
disease, mixed cryoglobulinemia.[7,8,9]  
CLASSIFICATION OF GLOMERULAR  DISEASES[1,7] 
Primary glomerular diseases: 
• Minimal change disease 
• Focal segmental glomerulosclerosis 
• Membranous nephropathy 
• Membranoproliferative glomerulonephritis 
• Diffuse endocapillary proliferative glomerulonephritis 
• Diffuse mesangioproliferative glomerulonephritis 
• Fibrillary and immunotactoid glomerulonephritis 
• Diffuse crescentic glomerulonephritis 
Secondary glomerular diseases : 
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• Lupus nephritis 
• Diabetic nephropathy 
• Hypertensive nephropathy 
• Amyloidosis 
• Good pasture syndrome 
• Glomerulonephritis secondary to lymphoplasmacytic disorders 
• Glomerulonephritis secondary to systemic vasculitis 
• Glomerulonephritis secondary to bacterial endocarditis 
Hereditary disorders : 
• Alport syndrome 
• Fabry disease 
• Thin basement membrane disease 
•  Congenital nephrotic syndrome – Finnish type and Diffuse  
   mesangial sclerosis. 
MINIMAL CHANGE DISEASE 
It is the most common cause of nephrotic syndrome in children 
accounting to about 80% to 90%. The peak  incidence in children is 
between 2 to 4 years. Males are more commonly affected than females. 
Majority of the cases are idiopathic. Minority of the cases can be 
associated with recent immunizations, viral infections, food allergies, 
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dust, bee stings, heavy metal ingestion, drug reactions to lithium, gold, 
interferon and ampicillin. Edema is the most common presenting 
symptom with some cases having microscopic hematuria.[7,9,34,35,38,39] 
Light microscopy shows no or minimal glomerular changes like 
mesangial hypercellularity. Tubular epithelial cells may show 
vacuolization or hyaline droplets. Edema and focal fibrosis in the 
interstitium can be seen in elderly patients.[7]  
Immunofluorescence studies are negative for immunoglobulin and 
complement. Mesangial deposits of IgM and C3 may be seen in 10% of 
cases.[8,9] Electron microscopy shows total effacement of foot process.[36] 
Differential diagnosis includes IgM nephropathy, C1q 
nephropathy, congenital nephrotic syndrome and FSGS.[8]  
IgM nephropathy shows no or mild mesangial proliferation on light 
microscopy with bright staining of IgM on immunofluorescence. 
Restriction of IgM nephropathy is given to only when there is bright 
staining of IgM on immunofluorescence.[8,9]  
C1q nephropathy shows variety of lesions ranging from no or 
minimal mesangial proliferative to active glomerulonephritis. When there 
is no change seen in the glomeruli, the diagnosis of MCD should be 
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considered. In immunofluorescence studies, MCD shows no staining 
whereas C1q nephropathy demonstrates bright staining for C1q.[9,11]  
FSGS poses problem in distinguishing it from MCD when the 
biopsy is small as FSGS affects only some glomeruli (focal). However, if 
there is classic segmental glomerulosclerosis there is no problem in 
making the diagnosis of FSGS. In case of small biopsies some features 
help in favoring one diagnosis or the other by considering glomerular 
size, presence of tubular atrophy, sampling from the deep cortex. Fogo et 
al found that patients with MCD and larger glomeruli had more likely 
chances of having FSGS on subsequent biopsies. Nyberg et al found that 
patients with FSGS had larger glomerular volume and diffuse mesangial 
sclerosis than in patients with MCD. Tubular atrophy near the glomeruli 
suggests the  possibility of  segmental lesion in the tissue near the biopsy, 
especially in children. If there is no segmental lesion then it is better to 
get the sample from juxtamedullary cortex as it is the first location of 
segmental lesions in FSGS.[8,36,37]  
Demonstration of mutations in the nephrin gene helps in the 
diagnosis of congenital nephrotic syndrome.[8,9]  
4% to 5% of the pediatric patients with minimal change nephrotic 
syndrome patients go for end stage renal disease or may die from 
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complications and 95% of them do well with steroid therapy according to 
Tarshish et al, 1997.[35]  
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 
Focal segmental glomerulosclerosis can occur as primary form due 
to unknown cause or secondary  due to familial mutations in various 
proteins like nephrin, podocin, integrin, laminins etc; viral infections; 
drugs; hereditary diseases; immunologic diseases. Primary FSGS 
accounts for 20% to 30% and 10% to 15% of nephrotic syndrome in 
adults and children respectively.[7,83,84]  
Kidney involvement starts at the  juxtamedullary region and spreads 
towards the periphery. Light microscopy shows sclerosis in one or more 
lobules of glomerular tufts with adhesions between the Bowman’s 
capsule and the tuft. There is often distortion and destruction of the 
glomerular architecture. There may be associated glomerular 
hypercellularity owing to podocyte proliferation and capillary collapse. 
As the FSGS progresses more number of glomeruli are involved with 
atrophy of the tubules and interstitial fibrosis. Sclerotic part of the 
glomeruli is PAS positive and JMS stain shows  remaining portion of 
glomerular basement membrane in the sclerotic areas as wrinkled lines.   
Immunofluorescence studies show non-specific staining for IgM and C3 
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in the sclerotic areas. Electron microscopy shows extensive foot process 
effacement which is more widespread in primary compared to secondary 
FSGS which shows patchy involvement.[7,8,41,47] 
Morphologic variants and histologic classification of FSGS : 
Columbia classification. 
Tip variant:  It is localized to the adjacent portion of the origin of 
the proximal convoluted tubule in the glomeruli. The lesion is small 
involving one or two lobules. Histologically, the lesion comprises of 
capillary loop occlusion by foam cells, endocapillary cell proliferation 
and sclerosis. Recent investigations show that tip variant has higher 
incidence of remission and 3 year renal survival rate than other 
variants.[7,42] 
Collapsing variant: It is characterized by segmental or global 
collapse of glomerular tuft along with podocyte hyperplasia or 
hypertrophy. Immunofluorescence findings are IgM and C3 positivity in 
segmental portion of the glomeruli. This variant has poor  prognosis with 
virtually no response to therapy and rapid loss of kidney function.[7,43,46,85] 
Perihilar variant : This variant shows perihilar sclerosis with 
hyalinosis in more than 50% of involved glomeruli.[9] 
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Cellular variant: This variant is characterized by atleast one 
glomerulus showing segmental endocapillary proliferation occluding the 
capillary lumen.[7,9] 
Not otherwise specified: This term is used when none of the above 
variants’ features are seen and segmental solidification of the glomerular 
tuft is noted. This is a diagnosis of exclusion.[7,9,10,41] 
Nasar Yousuf Alwahaibi et al, 2013 found that in Saudi Arabia and 
Sudan,  FSGS and MCD are the commonest primary glomerulonephritis 
respectively. Reports from India showed that FSGS is the commonest 
primary glomerular disease.[28]  
A study on Focal segmental glomerulosclerosis – morphologic 
diagnosis on evolution was done by David B. Thomas. This was an 
analytical study which included 197 patients with FSGS. According to 
this study, it was observed that FSGS Not otherwise specified was the 
most common form, followed by the perihilar type, collapsing type and 
tip lesion. Also patients that had collapsing and tip type of lesions 
manifested with higher degree of proteinuria than perihilar and FSGS 
NOS types.[44]  
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MEMBRANOUS NEPHROPATHY 
Membranous nephropathy accounts for 1% to 9% in children and 
20% to 30% in adults of all cases of idiopathic nephrotic syndrome. It can 
occur as primary (idiopathic) or secondary to infection, neoplasia or 
systemic lupus erythematosus, drugs and toxins, immunologic 
disorders.[7,8,51,82] 
It is characterized by the subepithelial immune deposits with 
variable GBM thickening without mesangial cell proliferation or 
inflammatory cell infiltration. Mechanism of injury occurs by deposition 
of the immnune complexes that are formed in-situ by binding of the 
circulating antibodies to the antigen that are present in the subepithelial 
location of glomerulus or with the extrinsic antigens that are planted as 
free antigens in the subepithelial region.[7,8] 
 By light microscopy four stages have been described based on the 
structural features of the glomerular capillary wall.[9,10] 
Stage 1: This is the early stage where there is no change in the 
glomeruli or in the thickness of the GBM. 
Stage 2: The capillary walls become thickened with subepithelial 
deposits. Silver impregnation techniques show spike formation along the 
thickened basement membrane.[9] 
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Stage 3: The deposits are surrounded by a newly formed basement 
membrane. The basement membrane becomes markedly thickened with 
narrowing of the capillary lumina. PAS and silver stains show 
reduplication or moth eaten appearance  of  the basement membrane.[8] 
Stage 4: The basement membrane show vacuolation, thickening and 
folding. Deposits may no longer be evident. Glomerulat tufts show 
segmental or global sclerosis and obliteration of the capillary lumina.[10] 
Tubules may show progressive atrophy and interstitial fibrosis as the 
glomerular lesion progresses. 
Immunofluorescence studies show generalized granular pattern of 
IgG and C3 along the GBM. Electron microscopy show subepithelial and 
sometimes intramembranous location of electron dense deposits.[7,8,9] 
Differential diagnosis includes minimal change disease, focal 
segmental glomerulosclerosis. Based on the characteristic 
histomophology, immunofluorescence studies and electron microscopic 
findings, membranous glomerulonephritis can be differentiated from 
other entities. Primary membranous glomerulonephritis should be 
differentiated from secondary form.[8,9]  
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MEMBRANOPROLIFERATIVE   GLOMERULONEPHRITIS 
Membranoproliferative glomerulonephritis is characterized by 
mesangial cell proliferation with basement membrane thickening. The 
main age group affected is between 5 years to 15 years. Males and 
females are equally affected.[7,8,55,56]  
Based on the causes, MPGN can be divided into primary and 
secondary. Primary is idiopathic and secondary occurs due to infections, 
immunologic disorders, neoplasia, and systemic diseases.[8,57,81] 
Based on histology and location of the immune deposits  MPGN can 
be subdivided into three  types. 
MPGN type 1 most commonly occurs in children. There is global 
and diffuse endocapillary and mesangial cell proliferation showing 
lobular accentuation and expansion of  mesangial matrix. There may be 
mononuclear cell infiltration with occasional neutrophils. There  is  
marked  thickening of  GBM producing a double contour or tram- track 
pattern when stained with PAS and silver stains. 
Immunofluorescence  studies are characteristic and  consistently 
show irregular chunky deposits in mesangium and capillary walls for IgG 
and C3. Sometimes IgM, C1q and C4 can also be seen in the same 
location. Electron microscopy shows abundant deposits in subendothelial 
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and mesangial areas, mesangial hypercellularity and accumulated 
matrix.[7,8] 
MPGN type 2 is also called as Dense Deposit Disease. It is less 
common than type 1 and type 3 MPGN. It is characterized by the 
intramembranous  dense deposits in the GBM which can be visualized by 
the electron microscopy. This is considered as pathognomonic feature of 
MPGN type 2 according to Appel et al, 2005.[51] 
Light microscopy shows typical  features of  MPGN with 
abnormally refractile, eosinophilic ribbon-like thickening of the basement 
membrane. The basement membrane changes can be demonstrated with  
PAS, Masson trichrome and Toluidine blue and silver stains in the 
glomeruli, tubules and peritubular capillaries. In addition, mesangium 
also shows dense deposits as homogenous nodules on electron 
microscopy.[8,9] 
Immunofluorescence studies show typical, diagnostic intense 
staining for C3 in the capillary walls and in the mesangium. C3 can also 
be detected in Bowman’s capsule and tubular basement membrane. 
Sometimes mild staining of C1q and C4 can be noted. Electron 
microscopy shows hallmark finding of dense, osmiophilic deposits in the 
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GBM, tubular basement membrane, Bowman’s capsule basal lamina and 
mesangial region.[7,8] 
Type 3 MPGN has mixed features of type 1 MPGN and 
membranous nephropathy. Hence light microscopy shows lobular 
accentuation on glomeruli, mesangial cell proliferation, diffuse capillary 
wall thickening and electron microscopy shows subendothelial and 
subepithelial deposits and silver stains demonstrate basement membrane 
spike. Immunofluorescence techniques show C3 in a finely granular 
pattern along glomerular capillaries and mesangium.[8,9] 
Appel et al, 2005 in their study concluded that in MPGN type 2, half 
of the patients develop end stage renal disease. The pathophysiology 
behind this type is high activation of the alternative pathway.[52]  
PD Walker et al, 2007 studied 81 cases of dense deposit disease and 
categorized them based on the histomorphological appearance into five 
different subtypes. The patterns observed were membranoproliferative 
(endocapillary proliferation with lobular accentuation in 17 cases);  
mesangioproliferative (30 cases); crescentic (12 cases); acute 
proliferative (8 cases) and unclassified (2 cases). They concluded that 
typical membranoproliferative pattern was seen in only 17 cases and 
majority of the cases showed other patterns. Hence dense deposit disease 
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should be considered as a different entity and not a subtype (type 2) of 
membranoproliferative glomerulonephritis.[53]  
DIFFUSE ENDOCAPILLARY PROLIFERATIVE 
GLOMERULONEPHRITIS. 
Diffuse endocapillary proliferative glomerulonephritis is 
characterized by lesions having mesangial and endocapillary cell 
proliferation. It is synonymous with acute post-streptococcal 
glomerulonephritis but this term is seldom used now since this may also 
occur after the infections by other organisms like staphylococci, 
meningococci, pneumococci, enterococci, Klebsiella, Salmonella, 
Brucella, Mycobacteria and various ricketssial and viral infections. It is a 
disease of childhood affecting children between 5 and 15 years, but can 
affect any age group. Clinically, patients present with nephritic syndrome 
after 1 to 4 weeks of nephrogenetic strain of beta hemolytic streptococcal 
infection in the skin or pharynx.[8,9,58,59,60,61] 
Light microscopy shows diffuse enlargement of the glomerular tufts 
by endocapillary,mesangial and epithelial proliferation with leucocytic 
infiltration (neutrophils and monocytes). Three patterns of 
immunofluorescence can be noted which are garland pattern (dense, 
discrete deposits of IgG and C3 seen as many humps on the subepithelial 
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side of the basement membrane); starry sky pattern (diffuse, irregular 
deposits of fine and granular type seen in both capillary loops and 
mesangium) and mesangial pattern (granular deposition of predominantly 
C3 and small amounts of IgG in the mesangium). Electron microscopy 
show subepithelial dome shaped deposits called humps.[8,9,10] Garland 
pattern is considered to have worse prognosis compared to starry sky and 
mesangial pattern.[10] 
Differential diagnosis: Non-streptococcal origin of acute post-
infectious glomerulonephritis should be considered as a differential 
diagnosis for post streptococcal glomerulonephritis. Clinical history of 
pharyngitis and skin infections (impetigo) and laboratory evidence of the 
organism help in differentiating these two entities. Also, electron 
microscopy shows more of subendothelial and intramembranous deposits 
in nonstreptococcal origin of acute post-infectious glomerulonephritis. 
Membranoproliferative glomerulonephritis can be differentiated 
from DPGN by subendothelial deposits in electron microscopy. 
Lupus nephritis class IV- diffuse proliferative type shows 
endocapillary proliferation with leucocytic infiltration. This can be 
differentiated from DPGN by clinical history, typical 
immunofluorescence and electron microscopy findings.[8]  
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DIFFUSE MESANGIOPROLIFERATIVE 
GLOMERULONEPHRITIS. 
Diffuse proliferation of mesangial cells and matrix expansion 
without involvement of capillary walls or lumina occurs in a variety of 
renal conditions including Ig A nephropathy, systemic lupus nephritis, 
Henoch Schonlein purpura, and resolving phase of post-infectious 
glomerulonephritis.[8,9] 
IgA NEPHROPATHY  
IgA nephropathy can occur at any age but most common age group 
affected is the second and third decades. Most common symptom is 
macroscopic hematuria. IgA nephropathy results from either deposition 
of immune complexes that are circulating because of binding of IgA to 
specific antigen planted in the mesangium or binding of IgA (abnormally 
glycosylated IgA1) to the mesangium in the absence of antigen. The 
circulating autoantigen-antibody complexes go through glomerular 
capillary fenestrae and stimulate the mesangial cells. These complexes 
play an important role in the pathogenesis of Ig A nephropathy.[63,64]  
Several biomarkers have been established recently in order to study 
the disease severity and progression. Among the biomarkers, elevated 
levels of galactose deficient IgA1, glycan-specific IgG and IgA1 auto-
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antibodies have been assessed and found that elevated levels of galactose 
deficient IgA1 associated with worse prognosis and patient outcome. 
Serum levels of IgG and IgA auto-antibodies are strongly associated with 
IgA nephropathy progression.[64,65] 
Light microscopy demonstrates a variety of histologic patterns 
ranging from normal to a diffuse crescentic glomerulonephritis.[8,62]  
Based on the light microscopy, IgA nephropathy can be classified into 
five stages (lee et al):[8] 
Stage I: Normal glomeruli or may show mesangial thickening with 
or without hypercellularity. Tubular and interstitial changes are absent. 
Stage II: Mesangial hypercellularity in less than 50% of glomeruli. 
Sclerosis and crescents are noted rarely. Tubular and interstitial changes 
are absent. 
Stage III: Diffuse along with focal and segmental mesangial 
proliferation variability is noted. Adhesions and crescents are 
infrequently seen. Rarely tubular atrophy and focal interstitial edema and 
inflammatory infiltration may be seen. 
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Stage IV: Striking diffuse mesangial proliferation and sclerosis is 
seen with crescents in 45% of glomeruli. Tubulointerstitial system shows 
atrophy, inflammatory infiltration and occasional foam cells. 
Stage V: Similar glomerular, tubular and interstitial changes as 
Stage IV but more severe. Crescents are seen in  more than 45% of 
glomeruli. 
Stage IV and V indicate worse prognosis. 
IgA nephropathy is diagnosed by immunofluorescence findings 
which show dominant diffuse mesangial and capillary loop deposits of 
IgA. Frequently C3 shows similar pattern as that IgA. Uncommonly,  
IgM and IgG can also show reactivity.[8,9] 
Differential diagnosis: Henoch Schonlein purpura has the similar 
histomorphological features as that of IgA nephropathy but can be 
distinguished from IgA nephropathy by the presence of extrarenal 
manifestations.[8]  
When IgG staining is as intense as IgA, lupus nephritis should be 
considered for differential diagnosis. If C1q staining is positive then the 
diagnosis of lupus nephritis is made because C1q staining is rarely seen in 
IgA nephropathy.[8,9]  
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In IgA- dominant post-infectious glomerulonephritis, dominant C3 
deposits in immunofluorescence studies, hump-like deposits on electron 
microscopy, polymorphs in histomorphology favours post-infectious 
glomerulonephritis.[8,9]  
C1Q NEPHROPATHY 
C1q nephropathy patients present with nephrotic syndrome and it 
usually  affects adolescents and young adults. Males are more commonly 
affected than females. It has relatively poor prognosis with 5 year 
survival rate being 78%.[9]  
Light microscopy shows spectrum of lesions ranging from minimal 
glomerular changes, mesangium expansion with mesangial 
hypercellularity, focal or diffuse proliferative glomerulonephritis.  
Segmental glomerulosclerosis may or may not be seen.  
Immunofluorescence studies show  predominantly C1q accompanied 
by C3 staining which is usually not as intense as C1q. IgA may be seen in 
about 60% of cases. Electron microscopy show mesangial immune 
complex deposits and foot process effacement.[9,10]  
       Differential diagnosis includes lupus nephritis. Patients with Lupus 
nephritis have typical clinical history of systemic lupus nephritis, and 
immunofluorescence studies show ‘full house’ pattern. Electron 
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microscopy shows characteristic reticular aggregates in lupus nephritis 
which is absent in C1q nephropathy.[9,10]  
FIBRILLARY AND IMMUNOTACTOID 
GLOMERULONEPHRITIS. 
These two types of glomerulonephritis are very rare and occur in 
older individuals. Light microscopic picture of both are very similar, 
showing mesangial hypercellularity, thickening of glomerular capillary 
walls, deposition of amorphous PAS-positive material. This deposit can 
be differentiated from amyloid by using with Congo red and thioflavin T 
stains.[7] 
Immunofluorescence studies in both show IgG and C3 distribution 
corresponding with the microtubules and fibrils.These two conditions can 
be differentiated only by electron microscopy studies. In both these 
conditions deposits can be found in subepithelial, subendothelial, GBM 
and mesangium. But immunotactoid glomerulonephritis show parallel 
arrangement of microtubular structures measuring 30 to 50 nm in width 
whereas fibrillary glomerulonephritis show deposition of  nonbranching, 
randomly arrayed fibrils measuring approximately 20 nm in diameter.[7,8] 
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DIFFUSE CRESCENTIC GLOMERULONEPHRITIS. 
Diffuse crescentic glomerulonephritis is termed as rapidly 
progressive glomerulonephritis or extracapillary proliferative 
glomerulonephritis. It is a severe type of glomerulonephritis with brisk 
and progressive loss of renal function  accompanied by hematuria, 
proteinuria, RBC casts in urine and severe oliguria.[1,7] 
Histopathologically,   the characteristic finding is crescent formation 
in 50% or more glomeruli.  Crescent formation occurs due to disruption 
in the glomerular capillaries which allows leucocytes, plasma proteins, 
fibrin into the Bowman’s space where they induce epithelial cell 
proliferation, macrophage maturation forming cellular crescents. Cellular 
crescents should be atleast two cell layer thick. As the disease progresses, 
cellular crescents become fibrous which are now called as  fibrocellular 
crescents. With further disease progression, cellularity is almost totally 
reduced forming a fibrous crescent.[7,8,9] 
There are three types of crescentic glomerulonephritis based on 
underlying pathologic mechanisms 
1. Anti-GBM glomerulonephritis 
2. Immune complex crescentic glomerulonephritis 
3. Pauci-immune crescentic glomerulonephritis 
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ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE 
This accounts for 15% cases of cresentic glomerulonephritis. It is an 
auto-immune disease occurring  as kidney limited or as pulmonary kidney 
syndrome (Goodpasture syndrome). This results  from antibodies against 
carboxyl terminus of the NC1 domain of the alpha 3 chain of type IV 
collagen.[7,8] 
The light microscopy shows typical necrotizing glomerulonephritis 
with crescent formation. Glomerular capillaries are often disrupted with 
neutrophilic infiltration and fibrin deposition. Severe involvement of 
glomeruli show intense periglomerular inflammation and Bowman’s 
capsule disruption which can be better visualized with silver stains. 
Immunofluorescence microscopy shows continuous linear staining 
in  the  glomerular capillaries for C3 and IgG. Electron microscopy show 
no immune complex deposition which is an important negative finding 
but disruption of GBM and fibrin deposition can be visualized.[8,9] 
IMMUNE COMPLEX CRESCENTIC GLOMERULONEPHRITIS. 
Immune complex crescentic glomerulonephritis accounts for 25% of 
all crescentic glomerulonephritis commonly occuring in children. It can 
be idiopathic or due to a complication of post-infectious 
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glomerulonephritis, types I and II MPGN, cryoglobulinemic 
glomerulonephritis, SLE, IgA nephropathy and HSP. 
Light microscopy show variable degree of glomerular capillary wall 
thickening and endocapillary cell proliferation along with some amount 
of necrosis. Immunofluorescence study show IgG granular deposition in 
capillary walls.[7,8,9,10] 
PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRITIS. 
It is the most common type of crescentic glomerulonephritis 
occurring in elderly patients and 80–90% of them are ANCA-positive. 
Serological markers for pauci-immune crescentic glomerulonephritis are 
anti-neutrophil cytoplasmic autoantibodies (either proteinase-3 or 
myeloperoxidase). 
Light microscopic picture is similar to anti-GBM disease. 
Immunofluorescence studies show small irregular focal staining for C3. 
Crescents show fibrinogen positivity. Electron microscopy demonstrates 
disruption of GBM and fibrin deposition.[7,8,9] 
LUPUS NEPHRITIS 
Systemic lupus erythematosus (SLE) is a chronic inflammatory 
auto-immune  disease involving various systems the etiology of which is 
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unknown. Prevalence of SLE in India ranges from 14 to 64 per 100,000 
population. Incidence of SLE in women is higher than in males with 
female to male ratio being 12:1. The common age group affected ranges 
from 15 to 45 years. Renal manifestation in SLE is called as lupus 
nephritis.[7,78] 
Most of the patients have no or slight renal symptoms. Usual finding 
is the abnormal urinary sediment or altered renal functional parameters. 
The clinical presentation does not always predict the underlying 
histological class of renal involvement.[72,73,74]   
All the four compartments i.e, glomeruli, tubules, interstitium, and 
blood vessels may be affected in lupus nephritis.  
International Society of Nephrology (ISN) / Renal Pathology 
Society (RPS) classification of lupus nephritis[7,8,9]  
It is the recent and widely accepted classification of lupus nephritis.  
Class I : Minimal mesangial lupus nephritis show no changes in 
glomeruli in light microscopy. Immunofluorescence studies show only 
mesangial deposits. 
Class II : Mesangial proliferative lupus nephritis is defined by 
any degree of mesangial cell proliferation and mesangial expansion. 
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Immunofluorescence shows mesangial immune complex deposits. 
Electron microscopy demonstrates rare subepithelial and subendothelial 
deposits.[7,8] 
Class III : Focal lupus nephritis consists of the global or focal and 
segmental,  endocapillary or extracapillary cell proliferation affecting less 
than half of the glomeruli. Active lesions are characterized by 
endocapillary proliferation and chronic lesions by healed,sclerosed 
changes. Some degree of necrosis, crescent formation and sclerosis can 
be seen. In necrotizing lesion, there can be hematoxylin bodies which are 
round masses to minute fragmented nuclei that show a lilac tinge on 
hematoxylin and eosin stained sections. These bodies are considered as 
pathognomonic of lupus nephritis but it can be seen only in 1-2% of 
cases. Active lesions show interstitial edema, inflammation whereas 
chronic stage shows atrophy of the tubules and fibrosis of the interstitium.   
Immunofluorescent microscopy reveals diffuse and global capillary wall 
and mesangial deposits for IgG, IgA, IgM, C3, and C1q. This is called as 
a ‘full house’ pattern. Fibrinogen is identifiable in crescents and 
necrotizing lesions. Electron microscopy shows mesangial, subepithelial 
and subendothelial deposits.[8,9,75] 
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III A : Active lesions 
III A/C : Active and chronic lesions 
III C : Chronic lesions 
Class IV : Diffuse lupus nephritis involves more than half of the  
glomeruli showing diffuse global or segmental endocapillary or 
extracapillary cell proliferation. There may be active and chronic lesions. 
The characteristic immune deposition in subendothelial location produces 
marked thickening  of the capillary walls to form ‘wire loop’ lesions. 
Capillary lumina may be occluded by heavy deposition of the immune 
complexes called as ‘hyaline thrombi’.  The activity and chronicity of the 
tubulointerstitial part corresponds to the activity and chronicity of the 
glomerular lesions.  Immunofluorescence shows a coarse granular pattern 
in the mesangium and in the capillary walls for IgG, IgA, IgM, C3, and 
C1q. Fibrin positivity is seen in crescentic necrotizing lesions. Electron 
microscopy shows mesangial and subendothelial deposits.[8,9,10,76] 
IV A: Active lesions 
IV A/C: Active and chronic lesions 
IV C: Chronic lesions 
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Jindal et al, who studied fatal complications of SLE in 25 cases 
observed that 96% of the cases showed kidney involvement. Of them, 
commonest lesion noted was diffuse proliferative glomerulonephritis 
comprising 60%. Rapidly progressive glomerulonephritis was seen in 7 
cases. All of them belonging to Class IV.[72] 
Tateno et al observed that massive lumpy deposits in the glomeruli 
were associated with severe diffuse proliferative class of Lupus nephritis 
which had a poor prognosis.[73]  
Class V: Membranous lupus nephritis shows the thickening of 
capillary basement membrane by the deposition of the immune 
complexes in subepithelial location. Glomeruli show mesangial cell 
proliferation and mesangial expansion. Silver stains show spike and dome 
pattern in the thickened capillary basement membrane. 
Immunofluorescence studies show IgG, IgA, IgM, C3 and C1q positivity 
in the capillary walls and IgG, IgM, C3 positivity in mesangium. Electron 
microscopy show subepithelial and mesangial deposits.[7,8] 
Class VI : Advanced sclerosing lupus nephritis is characterized 
by global sclerosis affecting more than 90% of glomeruli. 
Tubulointerstitium shows chronic changes like atrophy, inflammation, 
fibrosis and vessels show atherosclerotic changes. Some of the glomeruli 
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may have residual mesangial cellularity. Immunofluorescence and 
electron microscopy demonstrate granular immune deposits in the 
capillary wall and mesangium.[8,9] 
Klemperer et al., 1941 did a study on autopsy material and 
Muchreke et al.,1957 on percutaneousrenal biopsies and both these 
studies showed that kidney involvement in SLE is a frequent finding and 
a serious manifestation. Death by kidney involvement and need for 
kidney replacement therapy was seen in 15- 20% cases.  
Kanjanabuch et al., has shown in a study that lupus nephritis is the 
most common secondary form of glomerulonephritis followed by post-
infectious glomerulonephritis in developing countries. 
Rohi wani et al,2012., in a study on lupus nephritis showed that 
majority of the patients were females accounting 91.4% and the most 
common class of lupus nephritis was class IV accounting for 54. 29%. 
Banff et al, in a study of 147 patients with lupus nephritis found  
mesangial pattern  in class II and in few cases of class I and III, the 
peripheral pattern (lumpy and granular) was most common in class IV 
and VI whereas membranous pattern was noted in class V. 
Gladman et al, in a study of 148 biopsies, found that both active and 
chronic lesions are seen most commonly in Class III and IV of lupus 
42 
 
nephritis. Also, class I and class II LN showed active lesions in 17% and 
8% respectively which was due to interstitial inflammation. In class V 
there were 18% of cases having both active and chronic lesions.[77] 
McLaughlin found that 5 year survival rate was 86% in class I and 
30% to 79% in class IV. In the follow up study of cases of lupus 
nephritis, rapid increase in the serum creatinine levels is considered as a 
predictive  marker for  the progression of  irreversible renal failure. The 
main causes of death in SLE patients are irreversible renal failure, 
neurological manifestations and infections. 
DIABETIC NEPHROPATHY 
Diabetic nephropathy is considered as the leading cause for end-
stage renal disease. It is characterized by deposition of extracellular 
matrix in the glomerular and tubulointerstitial compartments along with 
the thickening and hyalinization of intrarenal vessels.[66,67,71] 
 The following lesions are seen in the diabetic nephropathy: 
Diffuse glomerulosclerosis is the most common lesion and is 
characterized by expansion of the eosinophilic, PAS-positive material in 
the mesangial matrix with segmental or diffuse capillary basement 
membrane thickening. There can be mild mesangial cell proliferation.[7,8] 
43 
 
Nodular glomerulosclerosis (Kimmelstiel Wilson lesion) is first 
described in 1936 by Kimmelstiel and Wilson. The lesion is characterized 
by accumulation of the round homogenous eosinophilic extracellular 
material in the mesangium and in capillary basement membrane. This 
material can be demonstrated by PAS, Masson trichrome, Mallory stains. 
Both nodular and diffuse glomerulosclerosis can be seen in the same 
glomeruli.[7] 
Insudative lesions, also called as hyalinosis are the electron dense, 
finely granular material containing lipid droplets seen in various regions 
of the glomeruli. When they are in the periphery of the loop in 
subendothelial region it is called fibrin cap and when they are within the 
basement membrane of the Bowman’s capsule it is called capsular 
drops.[7,8] 
Armani–Ebstein lesion is defined by vacuolization of the proximal 
tubular epithelial cells because of glycogen accumulation. 
Immunofluorescence studies are negative for immune deposits but 
show diffuse linear reaction for IgG along the glomerular capillary, 
tubular, and Bowman capsular basement membranes due to non-
immunological trapping of proteins in the altered basement membrane.[8] 
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Pathological classification of diabetic nephropathy (Thijs W. 
Cohen Tervaert et al, 2010)[70] 
Class I: Light microscopy show mild or nonspecific changes. 
Electron microscopy shows glomerular basement thickening (>395 
nanometer in females, >430 nanometer in males of 9 years of age or 
older). Biopsy should not meet any of the criteria for class II, III or IV.  
Class II a: Mild mesangial expansion in >25% of the observed 
mesangium. Biopsy does not meet the criteria for class III or IV.  
Class II b: Severe mesangial expansion in >25% of the observed 
mesangium. Biopsy does not meet the criteria for class III or IV.  
Class III: Nodular sclerosis (Kimmelstiel- Wilson lesion). Alteast 
one Kimmelstiel-Wilson lesion should be seen and biopsy does not meet 
the criteria for class IV. 
Class IV: Advanced diabetic glomerulosclerosis (Global sclerosis in 
>50% of glomeruli).  
Differential diagnosis: Hyalinosis lesion seen in diabetic 
nephropathy can also be seen in FSGS where usually the changes are 
focal and in DN it is more diffuse. The immunofluorescence and electron 
microscopy studies aid in distinguishing between these two lesions.[8]  
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Immune-complex mediated glomerulonephritis may be confused 
with DN. The presence of linear staining for IgG and albumin in 
immunofluorescence studies, absence of immune complex deposits in 
electron microscopy, thickening of glomerular basement membrane helps 
in making the diagnosis of diabetic nephropathy.[7,9]  
Hypertensive nephropathy or age related changes can be confused 
with diabetic nephropathy since both have thickening of glomerular 
basement membrane. Presence of hyaline arteriosclerosis is usually seen 
in DN which aids in making the correct diagnosis.[8]   
Nodular glomerulosclerosis in diabetes can be confused with 
amyloidosis, light chain deposition disease, membranoproliferative 
glomerulonephritis and immunotactoid glomerulonephritis. Amyloid is 
acellular and stains positive with Congo red stain and gives an apple 
green birefringence when visualized under polarized light unlike the 
nodules of diabetic nephropathy which stain negative for Congo red and 
positive for PAS stain. Furthermore, electron microscopy demonstrates 
amyloid as the classic rigid nonbranching fibrils of 8 to 10 nanometer  in 
diameter.[7,8,9] 
Light chain deposits are granular in appearance and 
immunofluorescence studies show either kappa or lamba staining in the 
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tubular basement membrane and sometimes in mesangial nodules and in 
GBM thus helping in distinguishing light chain deposition disease from 
diabetic nephropathy.[8,9] 
Immunotactoid glomerulonephritis can be differentiated from 
diabetic nephropathy by electron microscopy. The characteristic 
microtubules of 30 to 50 nm in width is seen in immunotactoid 
glomerulonephritis.[8] 
Membranoproliferative glomerulonephritis show diffuse 
involvement with similar degree of changes in all the glomeruli  whereas  
DN show focal changes in glomeruli. Mesangial cellularity is more 
pronounced in MPGN but in DN it is mild. With respect to nodules, 
diffuse and global involvement is seen in MPGN whereas it is focal and 
segmental in diabetic nephropathy. Methanamine silver stains 
demonstrates double contour of basement membrane, 
immunofluorescence studies show granular peripheral deposits and 
electron microscopy shows subendothelial and mesangial deposits in type 
I and intramembranous deposits in type II MPGN which further rules out 
the diagnosis of DN.[8,9,10] 
Diabetic nephropathy is the leading cause for end stage renal 
disease. A recent study from India shows that 31.3% of renal failure is 
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caused by diabetic nephropathy. Out of 114 cases of diabetes, 86 patients 
(75.43%) had diabetic nephropathy and remaining 28 had non-diabetic 
renal disease. Currently, not all the patients with a history of diabetes 
undergo renal biopsy. Biopsy is indicated only when there are atypical 
features noted in diabetic patients like absence of diabetic retinopathy, 
rapid onset of nephrotic syndrome or proteinuria, low or rapid decrease in 
glomerular filtration rate, presence of active urinary sediment and 
presence of signs and symptoms of other systemic diseases. They 
concluded that most of the patients with diabetes with kidney dysfunction 
have diabetic nephropathy. Most common class of diabetic nephropathy 
was class IV followed by class III, class II and class I.  Renal biopsy 
helps in staging of renal lesions in patients having diabetes with kidney 
dysfunction (M. Sahay et al, 2014).[69] 
HYPERTENSIVE NEPHROPATHY 
Hypertension is the elevation in systolic blood pressure more than 
140mm of Hg and diastolic blood pressure more than 90mm of Hg. When 
the gradient of the progressive rise in the blood pressure is slow it is 
called as benign phase of hypertension and when it is very steep it is 
called as malignant hypertension with blood pressure greater than 
200/120 mm of Hg.[1] 
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Benign hypertensive changes in the kidney 
Light microscopy shows wrinkling, thickening of the GBM with 
collapse, shrinkage of tuft; loss of tuft cellularity and obliteration of 
capillary lumina.[7,8]Tubules show atropy with thickening of basement 
membrane. Homogenous eosinophilic tubular casts may be seen. Arteries 
and arterioles show thickening of the walls with hyalinization.[8] 
Malignant hypertensive changes in the kidney 
Light microscopy show diffuse sclerosis in more than 50% of the 
glomeruli. Few glomeruli show fibrinoid necrosis with increase in 
cellularity by polymorphs and proliferation of the parietal cells. Few 
glomeruli show cellular crescents. Tubules show marked atrophy with 
hyaline casts and RBC casts in them. Arteries show thickening of the wall 
with onion skin appearance. Arterioles show typical fibrinoid necrosis.[8] 
AMYLOIDOSIS 
It is a group of disorders characterized by the extracellular 
deposition of amorphous, eosinophilic, nonbranching, linear, fibrillary 
protein. Amyloid is best demonstrated with Congo red stain and display a 
pathognomonic apple green birefringence when viewed under polarized 
light.[1,7,8] 
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Amyloidosis involving kidney can be of the following subtypes: 
AL amyloidosis which is related with plasma cell dyscrasias.  
AA amyloidosis which is associated with chronic inflammatory 
conditions.  
Dialysis related amyloidosis which occurs in patients undergoing 
long term dialysis and is caused by deposition of fibrillar beta-2 
microglobulin. 
Light microscopic changes include amyloid deposition in the 
mesangium initially which then involves the capillary walls. Tubular 
deposition of amyloid causes atrophy of the tubules and interstitial 
fibrosis. A variety of stains are used to demonstrate amyloid like Congo 
red, Thioflavin T and S, crystal violet stains. The most reliable method is 
demonstration  of an apple-green color by polarized light in Congo red 
stained sections. 
Immunofluorescence studies show that amyloid is auto-fluorescent 
under ultraviolet light. Non-specific staining of deposits for IgM and C3 
are sometimes noted.[7,8] 
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MYELOMA CAST NEPHROPATHY 
Myeloma cast nephropathy is the most common kidney disorder in 
the multiple myeloma patients. It is seen in approximately half of the 
patients who have kidney disease in multiple myeloma. Other renal 
manifestations that are encountered are amyloid (light chain or heavy 
chain deposition), acute tubular damage or necrosis, inflammatory 
tubulointerstitial nephritis, heavy chain deposition. Infiltration of the 
plasma cells into the kidney is a rare finding.  
Cast nephropathy typically presents with acute renal failure with 
nephrotic range proteinuria composed predominantly of Bence Jones 
protein.  
        The glomeruli and vessels may appear normal by light microscopy. 
The distal and proximal tubules show casts which appear dense, 
eosinophilic, irregular, angulated, fracture planes. The casts are composed 
of  Bence Jones, Tamm-Horsfall or light chain proteins. The tubules are 
frequently surrounded by giant cells and inflammatory cells giving a 
granuloma-like inflammatory reaction. There is associated chronic 
inflammatory cell infiltration, tubular atrophy, denudation and necrosis.  
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Immunofluorescence studies show either kappa or lambda positivity 
in the casts. Electron microscopy show casts having crystalline structures 
of varying sizes and shapes.[7,8,9]  
GLOMERULAR LESIONS ASSOCIATED WITH 
VASCULITIS 
A variety of primary and secondary vasculitis are known to have 
renal involvement. Polyarteritis nodosa, Henoch-Schonlein purpura, 
Wegener’s granulomatosis and microscopic polyangiitis are some of the 
common lesions affecting the kidney.[1] 
POLYARTERITIS NODOSA 
The kidneys are affected in 80-90% of the cases. The acute phase 
shows fibrinoid necrosis of the vessel wall. Initially,  the inflammation 
and necrosis is seen on the inner wall which spreads transmurally leading 
to the  perivascular involvement. In the chronic phase there is extensive 
destruction of the wall with replacement by fibrosis. Immunofluorescence 
studies and electron microscopy show no immune complex 
deposition.[1,7,8] 
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HENOCH-SCHONLEIN PURPURA 
The light microscopic changes in HSP are variable. Glomerular 
changes may range from apparently normal looking to diffuse 
proliferative and crescentic glomerulonephritis. Immunofluorescence 
studies show predominant mesangial deposition and weak staining in the 
capillary walls for IgA.[7,8] 
MICROSCOPIC POLYANGIITIS 
Light microscopy shows effacement of the glomerular architecture 
by extensive sclerosis along with destruction of Bowman’s capsule, 
periglomerular fibrosis and chronic inflammation.  Immunofluorescence 
studies show intense fibrin staining in the interlobular arterial wall.[8] 
WEGENER’S GRANULOMATOSIS 
The most common lesion in Wegener’s granulomatosis is focal 
necrotizing glomerulonephritis with crescents. Interstitium shows 
inflammatory infiltrates.[7,8] 
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HEREDITARY GLOMERULAR DISEASES 
ALPORT SYNDROME 
It is an inherited disorder of the basement membrane (type IV 
collagen). 90% of the patients  have X-linked dominant inheritance with 
remaining cases being autosomal recessive or autosomal dominant.[7,8] 
Light microscopy findings are nonspecific with glomeruli showing 
mild mesangial cell proliferation and mild thickening of the capillary 
basement membrane. Interstitium show foamy cells. As the disease 
progresses the glomeruli undergo global or segmental sclerosis. 
Immunofluorescence studies show scattered deposits of IgM and C3. 
Electron microscopy shows transformation of the lamina densa into 
multiple interwoven lamellae that enclose electron-lucent areas 
containing round granules of variable density.[8] 
THIN BASEMENT MEMBRANE DISEASE 
This is a hereditary renal disease characterized by the uniform 
thinning of the basement membrane. Light microscopy show erythrocytes 
in the Bowman’s space and renal tubules but otherwise appear normal. 
The diagnosis is made by the characteristic ultrastructural 
demonstration of uniform thinning of the GBM (lamina densa). The 
54 
 
width is reduced to one-third (approximately 200 nm), and on occasion 
ruptures of the GBM may be seen. Immunofluorescence studies are 
usually negative for immunoglobulin and complement.[7,8,9] 
FABRY DISEASE 
It is an uncommon inherited X-linked disease. It is caused by a 
deficiency of a-galactosidase A enzyme found in lysosomes resulting in 
accumulation of neutral glycosphingolipid globotriaosylceramide in the 
tissues. Kidney involvement manifests in the second decade with 
hematuria and proteinuria.[7] 
On light microscopy, vacuolization of the visceral and parietal 
epithelial cells, endothelial cells, mesangial cells, tubular epithelial cells 
are noted. These vacuoles are PAS negative. As the disease progresses, 
glomeruli undergoes segmental or global sclerosis with interstitial 
scarring and arteriolar hyalinosis.  
On electron microscopy, characteristic ‘zebra bodies’ are seen in the 
affected cells. Zebra bodies are laminated inclusions which are either 
round with a concentric myelin-like structure or ovoid with parallel layers 
seen in the cytoplasm.[7,8]  
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CONGENITAL NEPHROTIC SYNDROME 
The patients present with clinical symptoms at birth or within few 
months of age. Two major types of congenital nephrotic syndrome are 
congenital nephrotic syndrome of the Finnish type and diffuse mesangial 
sclerosis.[7] 
CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH 
TYPE 
         It is a rare disease with  autosomal  recessive mode of inheritence 
having mutations of the NPHS1 gene located on chromosome 19q13. 
The most characteristic feature in light microscopy is proximal and 
distal tubular ectasia with flattening of the tubular epithelial cells. There 
may be increased number of immature glomeruli.[8] 
Immunofluorescence studies may show mesangial and capillary 
staining for IgM and C3.[7,8] 
DIFFUSE MESANGIAL SCLEROSIS 
It is characterized by the early onset of severe proteinuria. Patients 
will rapidly progress to end-stage renal failure within 3 years of age. 
Light microscopy show diffuse mesangial sclerosis but do not show 
increased cellularity. Occasionally crescents may be seen. 
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Immunofluorescence studies show IgM and C3 deposits outlining 
the sclerosed glomeruli and IgM, C3 and C1q deposits in the mesangium 
of the slightest affected glomeruli.[7,8] 
TUBULOINTERSTITIAL DISEASES 
ACUTE TUBULAR NECROSIS 
The two features of ATN are acute renal failure and epithelial cell 
injury. The two types of ATN are ischaemic and toxic ATN.  
ISCHAEMIC ATN: 
Ischaemic ATN is caused by decreased perfusion of the kidneys and 
is the most common type. Hypoperfusion of the kidneys results from 
various causes like burns, shock following surgeries, septic shock after 
pancreatitis, dehydration because of vomiting, diarrhea or increased 
sweating.    
The light microscopy changes depend upon the extent of severity of 
renal failure and evolution of the disease. Glomeruli are usually spared. 
Tubular epithelial cells show swelling, vacuolation, loss of brush border, 
and denudation. Tubules may commonly show epithelial, hyaline or 
granular casts which are PAS-positive. Interstitium shows edema and 
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mononuclear cell infiltration. Later stages may show evidence of tubular 
epithelial cell regeneration.[7,8,9]  
TOXIC ATN:  
Toxic acute tubular necrosis can be caused by wide variety of 
substances like chemotherapeutic agents, organic solvents, heavy metals, 
antibiotics and radiographic contrast agents. Some of the endogenous 
components like hemoglobin and myoglobins also causes ATN.[7,68] 
Light microscopy shows extensive necrosis of the tubular epithelial 
cells with pigmented casts. Immunofluorescence studies show non-
specific linear staining for IgG and C3 in the tubular basement membrane 
in some drug-induced ATN. Electron microscopy shows evidence of 
interstitial edema, inflammatory cell infiltration and tubulitis. Immune 
complex deposits are not seen.[7,8] 
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RENAL BIOPSY 
The first renal biopsy was performed a century ago in 1901 for the 
treatment for Bright disease as a part of renal decapsulation procedure. 
Open renal surgical procedure was done by Gwyn in 1923 and 
percutaneous renal biopsy was performed only in 1951 by Iverson and 
Brun. A few years later in 1954, a descriptive procedure of  patients lying 
in prone position for renal biopsy was published by Kark and Muehrcke. 
Presently, new ultrasound guided renal biopsy is the gold standard 
procedure with minimal complications.[2,3,12,17]  
Indications for renal biopsy :  
Isolated  hematuria, mild, moderate and severe proteinuria, acute 
and chronic renal failure, glomerulopathies, renal manifestations of 
systemic diseases. Renal biopsy also plays an important role in renal 
transplantation.[3,12]  
Contraindications for renal biopsy:  
There are absolute and relative contraindications for renal biopsy. 
Some of the absolute contraindications are uncooperative patients, 
pregnancy, uncontrolled bleeding diathesis and anatomic malformations. 
Relative contraindications are renal abscesses, hydronephrosis, 
pyelonephritis, severe anemia, marked obesity, uremia, uncontrolled 
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hypertension or hypotension, large renal tumors, arterial aneurysms and 
cysts.[3,14]  
Procedure :  
Ultrasound guided percutaneous renal biopsy is the gold standard 
method to obtain renal biopsy. It is usually carried out by the nephrologist 
or radiologist according to the local practice.[12,18]  
Adequacy of the tissue sample :  
1. Biopsy must include 8 to 10 glomeruli. 
2. Juxtamedullary glomeruli ( preferential involvement in FSGS). 
3. In case of focal lesions, a minimum of 25 glomeruli should be in 
the biopsy tissue to look for the evidence of renal injury. 
4. In case of diffuse lesions even one glomeruli is considered 
sufficient to make a diagnosis.[3,12,13,14]  
Complications of the procedure :  
Minor : Gross hematuria, silent hematuria 
Major : Hematoma 
Catastrophic : Loss of functional mass, death.[3] 
Clinical information necessary for the pathologist:         
 Pathologists will need to know the detailed clinical history, past 
history of diabetes mellitus, hypertension, laboratory investigations like 
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urine analysis particularly hematuria, proteinuria, pyuria, serum 
creatinine, blood urea nitrogen values, total protein, cholesterol, C3 and 
C4 levels, antinuclear antibodies, anti-neutrophil cytoplasmic antibodies, 
current treatment if any.[14]  
 Handling of the specimen :  
Two core biopsy specimens, each divided into three portions for 
light microscopy, immunofluoroscence studies and electron microscopy. 
Biopsy for immunofluorescence studies is sent in Michel transport 
medium. For light microscopy 10% neutral buffered formalin can be used 
as transport medium as well as fixative. For electron microscopy, ice cold 
1% to 3% glutaraldehyde can be used as fixative.[2,12,14] 
Light microscopy :  
2 to 3 micron thickness serial sections are taken for light 
microscopy. Number of stains can be used for light microscopy. Routine 
haematoxylin and eosin stain is considered best to visualize the cell 
morphology. Periodic acid Schiff stain can be used to highlight the 
basement membrane and connective tissue matrix. Methanamine silver 
stains are mainly used to see the basement membrane and are better than 
PAS in highlighting the basement membrane abnormalities. Use of 
haematoxylin and eosin in place of neutral green in methanamine silver 
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stain has an added advantage of examining the relations between matrix 
and glomerular cells. Other stains like Congo red can be used in 
suspicious cases of amyloidosis (heavy proteinuria, systemic 
amyloidosis), elastin stain can be used in cases of vascular renal 
diseases.[12,14]   
Immunofluorescent microscopy: 
Tissue is snap-frozen for immunofluorescence and serial sections of 
2 to 3 micron thickness is cut and placed on the air-dried slides. A panel 
of antibodies for the immunoglobulins (IgG,IgA,IgM), complements (C3, 
C4, C1q), fibrin, kappa and lambda light chains are added to the sections. 
The fluorescence is visualized under the fluorescent microscope. While 
reporting the positive staining the pathologist should note the intensity 
and pattern or localization (linear or granular deposits along basement 
membrane, mesangial) of the fluorescence.[14]  
There are few advantages and disadvantages of this method. This 
method is comparatively easy and quick. Disadvantages would be a 
separate core tissue must be taken at the time of biopsy for this study. A 
cryostat for sectioning and fluorescent microscope to visualize the slides 
are a must for this method. An aqueous medium which is the mounting 
medium is not permanent. Exposure to light causes bleaching. To prevent 
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from bleaching, slides can be stored in dark in the refrigerator. 
Photographs of the relevant slides can be taken for future references.[12,14]  
Electron microscopy: 
Tissue for electron microscopy is transformed into plastic and ultra-
thin sections are taken and stained with heavy metal stains like lead 
citrate and uranyl acetate. One or two glomeruli, vascular structures and 
tubulointerstitial areas are examined under low, medium and high 
magnification. Photomicrographs are taken of the pathological 
abnormalities.[12,13]   
Reporting of the renal biopsy: The final report should include the 
following information: 
• Number of glomeruli and the arteries (adequacy of the tissue). 
• Histomorphological changes in each compartment of the kidney 
tissue in a systematic order (glomeruli, tubules, interstitium, 
vessels).  
• Immunofluorescence study results. 
• Electron microscopy results.  
The final diagnosis is given after carefully correlating all the above 
findings.[13,16] 
  
 
 
 
 
MATERIALS AND 
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MATERIALS AND METHODS 
SOURCE OF DATA  
The present study “The value of immunofluorescence in renal 
diseases with special reference to Periodic acid Schiff and Jone’s 
methanamine silver stain” was conducted in the Department of 
Pathology, Coimbatore Medical College, Coimbatore from October 2012 
to July 2014. A total of 58 cases, two renal biopsies for each case, one in 
formalin and other in Phosphate buffer solution were received. The study 
was performed based on the following proforma.  
INCLUSION CRITERIA 
Renal  biopsy specimens of the patients of  all age groups and both 
sexes with altered renal function suggestive of kidney disease from the 
Department of Nephrology, Coimbatore Medical College and Hospital, 
Coimbatore were included in this study. 
EXCLUSION CRITERIA 
1. Specimen not received in phosphate buffer solution for 
immunofluorescence studies. 
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2. Specimens that are very tiny for processing and considered 
inadequate with no glomeruli in subsequent serial sections for light 
microscopy.  
3. Specimen without required clinical and histopathological details. 
4. Clinically suspected cases of diabetic nephropathy.  
5. Patients that are considered unfit for biopsy (coagulation 
abnormalities, poor cardiac function). 
Indications for biopsy: 
1. All nephrotic syndrome and nephritic syndrome patients who 
are willing for renal biopsy. 
2. Patients with acute renal failure not recovering within 4 weeks 
of duration. 
3. All patients with systemic lupus erythematosus who are willing 
for biopsy. 
METHODS OF COLLECTION OF SAMPLE 
Before the procedure a pre-renal anaesthetic assessment including 
prothrombin time, bleeding time, complete blood count were checked and 
xylocaine needle test dose was given. 
After obtaining informed consent, under local anaesthesia and 
aseptic precautions, two cores of percutaneous ultrasound guided biopsy 
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specimens of kidney were taken from the patients with altered renal 
functions. One core was sent in 10% neutral buffered formalin for routine 
light microscopic examination and other was sent in phospate buffer 
solution (pH 7.4) for immunofluorescence studies. The procedure was 
performed with an informed consent by the clinician as a routine 
procedure for diagnosis and treatment.  
LIGHT MICROSCOPY 
The renal tissue obtained in 10% neutral buffered formalin is kept 
for fixation for 12 hours to 24 hours and it is then processed and 
embedded in paraffin. The sections of 3µ to 4µ thickness were cut and 
stained using haematoxylin and eosin.  
Special stains like Periodic Acid Sciff and Jone’s methanamine 
silver stain were performed to look for the abnormalities in the 
glomerular basement membrane.  
 HAEMATOXYLIN AND EOSIN STAIN 
Materials required: 
A. Ehrlich’s haematoxylin 
B. Xylol  
C. Absolute isopropyl alcohol I and II 
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D. 90% isopropyl alcohol 
E. 1% eosin (1gram eosin + 100 ml of distilled water) 
F. 1% acid alcohol (99 ml of isopropyl alcohol + 1 ml concentrated    
hydrochloric acid) 
Procedure :  
1. Paraffin sections of thickness 3µ to 4µ were taken on egg albumin 
coated slides. 
2. Air dry the slides and dewax them (62c to 64c). 
3. Transfer the sections immediately to xylene for 30 minutes. 
4. Sections are then transferred to absolute alcohol I and II and 90% 
alcohol for 15 minutes. 
5. Bring the sections to water. 
6. Clean the slides around the sections. 
7. Transfer the sections to Ehrlich’s haematoxylin for 15 to 20 
minutes. 
8. Drain the slides and wash them in tap water. 
9. Dip the slides 2 to 3 times in 1% acid alcohol. 
10. Wash the slides in tap water. 
11. Keep the slides in washing tray (for blueing) for 10 to 15 minutes. 
12. Slides are dipped 3 to 4 times in 1% eosin. 
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13. Wash the slides in several changes of water till the water becomes 
colourless. 
14. Air dry and clear the sections using xylol  
15. Sections are mounted with DPX mountant. 
Results :  
Nuclei – Blue.  Cytoplasm – shades of pink.  
PERIODIC ACID-SCHIFF STAIN 
Materials required :  
A.  Periodic acid  
B. Basic fuschin 
C. 1 Normal Hydrochloric acid  
D. Sodium metabisulphite 
E. Activated charcoal 
F. Distilled water 
G. Haematoxylin 
0.5% periodic acid preparation :  
Periodic acid       -  0.5 gram 
     Distilled water      -  100 millilitre 
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Schiff reagent preparation: 
      Dissolve 1 gram of Basic fuchsin  in  200 ml of boiling water. Cool to  
50˚C,  add 20 millilitre of  1 Normal  Hydrochloric acid . Cool further 
and add 1 gm of anhydrous sodium bisulphate. Keep it in the dark for 48 
hours. Then add 2 gms of activated charcoal until the solution becomes 
straw yellow colour. Filter the solution.  Keep it in brown bottle at 4˚C.  
Procedure: 
1. Deparaffinize the sections and bring it to water .     
2. Oxidize with 0.5% Periodic  acid for 5 minutes. 
3. Wash  with  tap  water  for 5 minutes. 
4. Use Schiff  reagent on the sections for 15 minutes. 
5. Wash with water for 10 minutes. 
6. Transfer the sections to Haematoxylin for 15 minutes. 
7. Wash with water (till blueing) for 10 minutes. 
8. Differentiate with 1% Acid alcohol. 
9. Wash in running tap water for 5 minutes. 
10.  Dry, clear the sections with xylene and mount with DPX 
mountant.  
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Results:  
Nuclei – blue. 
Basement membrane and PAS positive material – magenta pink 
JONE’S METHANAMINE SILVER STAIN 
Reagents required:  
1. 1%  aqueous  periodic  acid 
2. Hexamine silver solution. 
3. 5% borax. 
4. 0.1% aqueous  gold  chloride 
5. 5% aqueous  sodium  thiosulphate 
6. 0.2% light green  in  0.2% acetic  acid. 
Stock hexamine silver solution:  
Mix 5 ml of 5% aqueous silver nitrate and 100ml of 3% aqueous 
hexamine (synonym: methanamine or hexamethylenetetranium). A white 
precipitate forms that dissolves on shaking. The solution is kept for the 
limited time (1 to 2 months) if stored in a dark container at 4˚c. 
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Working Hexamine Silver solution: 
Dilute 2ml of a 5% aqueous sodium borate solution with 25ml of 
distilled water. Mix and then add 25ml of the stock Hexamine Silver 
solution.  
Procedure : 
1. Bring sections to distilled water. 
2. Treat with 1% periodic acid  solution  for  10 minutes. 
3. Wash well in several changes of distilled water. 
4. Place in working hexamine  silver  solution in 56˚c for 20 
minutes and examine subsequently at frequent intervals until  
the basement  membranes  are  blackened. 
5. Wash well in  two changes  of distilled water each for 5 
minutes. 
6. Tone in 0.1% aqueous yellow gold chloride for 2 to 5 minutes.  
7. Wash in water and treat with 5% aqueous sodium  thiosulphate  
for 5 minutes. 
8. Wash in water, counterstain in 0.2% light green in 0.2% acetic 
acid for 1 minute. 
9. Dehydrate, clear and mount in DPX mountant.  
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Results:  
               Basement membranes (Basal lamina)  - Black. 
                Background - Green. 
IMMUNOFLUORESCENCE 
Preparation of phosphate buffer saline (pH 7.4) 
Disodium hydrogen phosphate          - 8.5gram 
Potassium   dihydrogen phosphate     - 1.5 gram 
Sodium   chloride                                - 8.0 gram 
Distilled   water                                   - 1000 milliliter 
Preparation of Buffered Glycerol mounting medium: 
Glycerol                          – 9 ml  
Phosphate Buffer Saline – 1 ml 
Procedure:  
1. The biopsy was received in phosphate buffer saline (pH 7.4). 
2. Wash the tissue in distilled water to remove blood clot if any. 
3. Take sections in Leica CM 1510 S cryostat machine at -24 degree 
Celsius temperature using Tissue tek embedding medium at 3 to 4 
micron thickness. 
72 
 
4. Dry the sections at room temperature in dark for  2 hours atleast. 
Keep the sections in the chill tray of refrigerator. 
5. Take the slides from the chill tray and keep them in dark room for 
30 minutes to 1 hour to bring them to room temperature. 
6. Fan dry the slides at room temperature for 10 minutes. 
7. Choose the slide with glomeruli by observing under phase contrast 
microscopy. Slides with even one glomerulus were selected and 
subjected for immunofluorescence studies.  
8. Mark the slides with diamond marker. 
9. Wash the sections with PBS for 10 minutes.  
10. Drain off the excess PBS and wipe around the sections using tissue 
paper.  
11. Cover the sections with diluted Fluorescent isothiocyanate 
conjugated antibodies IgG, IgA, IgM, C3c, C1q and Fibrinogen 
(1:20 dilution with PBS) for two hours in room temperature in dark 
environment.  
12. Wash the sections with PBS for 10  minutes each (3 changes). 
13. Drain off the excess PBS and wipe around the sections using 
tissue paper.  
14. Mount the slides with one to two drops of buffered glycerol 
mounting medium and cover slip was applied. 
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15. Examine under the fluorescent microscope in a dark environment. 
16. Pictures were taken using the camera and preserved in the 
computer for future reference. 
17. The slides were stored in the refrigerator for a week.  
    Result:  Green fluorescence  -  Positive.  
                  Background – black. 
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OBSERVATION AND RESULTS 
The present study is a prospective study of renal biopsies received 
over a period of 20 months. The total number of biopsies received are 58 
from the Department of Nephrology, Coimbatore Medical College and 
Hospital, Coimbatore.  
AGE DISTRIBUTION OF CASES 
The patients were divided into six groups depending on their age at 
presentation.  
GROUP 1 : 1-10 YEARS 
GROUP 2 : 11-20 YEARS 
GROUP 3 : 21-30 YEARS 
GROUP 4 : 31-40 YEARS 
GROUP 5 : 41-50 YEARS 
GROUP 6 : 51-60 YEARS 
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TABLE 1: AGE DISTRIBUTION OF THE CASES 
Age Frequency Percent 
1 – 10 years 1 1.7 
11 – 20 years 13 22.4 
21 – 30 years  10 17.2 
31 – 40 years 16 27.5 
41 – 50 years 15 25.8 
51 – 60 years  3 5.1 
Total 58 100.0 
 
 
N Mean 
(Years)  
Median 
(years) 
Standard deviation Minimum 
(years)  
Maximum 
(years) 
58 33.03 35.00 12.54 9 57 
 
 
 
 
 
 
 CHART 1: 
 
The highest number of patients
years (16) which constituted 27.5% of patients
41 years to 50 years (15) whic
mean age was 33.03 years and median was 35 years. The youngest patient 
was 9 years and the oldest patient was 57 years. 
The most common
years) and 4 (31years to 40 
glomerulonephritis. The most
(between 1 year to 
in the age group
glomerulonephritis. 
1 - 10 years 11 
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AGE DISTRIBUTION OF THE CASES
 were in the age group 31years to 40 
 followed by the age group 
h constituted 25.8% of the patients
 
 lesion in the age groups 3 (between 21years
years) was diffuse proliferative 
 common lesion in the groups 1 and 2 
20 years) was focal segmental glomerulosclerosis and 
 5 (41 years to 50 years) was membranous 
Patients belonging to group 6 (between 51 years to 
1.70%
22.40%
17.20%
27.50%
25.80%
5.10%
- 20 years 21 - 30 years 31 - 40 years 41 - 50 years 
 
 
. The 
 to 30 
51 - 60 years
 60 years) had the diagnoses of
membranoproliferative glomerulonephritis and mesangioproliferative 
glomerulonephritis. 
TABLE 2: GENDER DISTRIBUTION OF THE CASES
Gender 
Male 
Female 
Total 
 
CHART 2:
 
To the above table Z test has been applied and it was noted that the
was equidistribution of patients
cases, 28 patients were male
females constituting 
0.933:1. The most common glomer
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 diffuse proliferative glomerulonephritis, 
 
Frequency Percent
28 48.27
30 51.72
58 100.0
 GENDER DISTRIBUTION OF THE CASES
 among males and females. Of the 58 
s constituting 48.27% and 30 patients
51.27%. The male to female ratio was found to be
ular lesion noted in males was d
MALE -
48.27%
FEMALE-
51.72%
MALE FEMALE
 
 
 
 
 
 
 
re 
 were 
 
iffuse 
 proliferative glomerulonephritis (10 out of 28 
Lupus nephritis (7 out of 30 cases). 
TABLE 3: 
AGE 
1 – 10 
YEARS 
11 – 20 
YEARS 
21 – 30 
YEARS 
31 – 40 
YEARS 
41 – 50 
YEARS 
51 – 60 
YEARS 
TOTAL 
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AGE AND GENDER DISTRIBUTION OF THE 
CASES. 
GENDER 
MALE FEMALE 
1 0 
3.5% 0% 
9 4 
69.23% 30.77% 
5 5 
17.85% 16.66% 
6 10 
37.5% 62.5% 
5 10 
17.85% 33.33% 
2 1 
17.14% 3.33% 
28 30 
100.0% 100.0% 
 
GENDER DISTRIBUTION OF THE CASES
69.23%
17.85%
37.50%
17.85% 17.14%
30.77%
16.66%
62.50%
33.33%
3.33%
11-20 
YEARS
21- 30 
YEARS
31-40 
YEARS
41- 50 
YEARS
51- 60 
YEARS
n females was 
TOTAL 
1 
1.7% 
13 
22.4% 
10 
17.2% 
16 
27.5% 
15 
25.8% 
3 
5.1% 
58 
100.0% 
 
 
MALE
FEMALE
 TABLE 4: DISTRIBUTION OF CASES BASED ON BLOOD UREA 
BUN (mg/dl) 
Normal (7-20.0)
High ( >20.0) 
total 
CHART 4: DISTRIBUTION OF CASES BAS
UREA NITROGEN VALUE (mg/dl) 
 
Of the 58 patients, 53 patients
nitrogen value ( > 20.0 mg/dl
patients (8.62%) 
glomerulosclerosis (1
membranoproliferative 
nephropathy(1patient
79 
NITROGEN VALUE (mg/dl) 
 
Frequency Percent
 
5 
53 91.38
58 100.0
 
ED ON BL
 
 (91.38%) had high blood urea 
). Blood urea nitrogen value was normal in
whose diagnoses included focal segmental 
patient), minimal change disease (1
glomerulonephritis (1patient
) and acute tubular necrosis(1patient
8.62
91.38
Normal (7
High  (>20.0 mg/dl)
 
8.62 
 
 
OOD 
 
 5 
patient), 
), IgA 
).  
-20.0 mg/dl)
 TABLE 5: DISTRIBUTION OF 
Serum creatinine (mg/dl)
Normal (0.6-1.2) 
High (>1.2) 
total 
 
CHART 5: DISTRIBUTION OF CASES BASED ON SERUM 
 
Of the 58 patients
value and 10 patients (17.24
diagnoses included
focal segmental glomerulosclerosis(2 patients), IgA nephropathy (2 
patients), mesangioproliferative glomerulonephritis (1 patient), and 
membranoproliferative 
80 
CASES BASED ON SERUM 
CREATININE LEVEL (mg/dl) 
 Frequency 
10 
48 
58 
CREATININE LEVEL (mg/dl) 
, 48 patients (82.76%) had high serum creatinine 
%) had normal serum creatinine value whose 
 diffuse proliferative glomerulonephritis (4 patients), 
glomerulonephritis (1patient).   
17.24 %
82.76 %
Percent 
17.24 
82.76 
100.0 
 
Normal (0.6-1.2)
High (>1.2)
 TABLE 6: DISTRIBUTION OF CASES BASED ON 24 HOURS 
URINE PROTEIN LEVELS ( g/day)
Urine protein (g/day)
<3.5 
>/=3.5 
Total 
CHART 6: DISTRIBUTION OF CASES BASED ON 24 HOURS 
URINE
 
Of the 58 patients
excretion of more than 3.5 grams/day (nephrotic 
diagnoses included
Focal segmental glomerulosclerosis (4 patients), membranoproliferative 
glomerulonephritis (4 patients), membranous nephropathy (3 patients), 
lupus nephritis (3 patients), minimal change disease (2 pa
chronic glomerulonephritis (1 patient).
39.66%
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 Frequency 
35 
23 
58 
 
 PROTEIN LEVELS ( g/day) 
, 23 patients (39.66%) had a 24 hour urine protein 
range proteinuria) whose 
  diffuse proliferative glomerulonephritis ( 6 patients), 
 
60.34%
Percent 
60.34 
39.66 
100.0 
 
tients) and 
<3.5 g/day
>/=3.5 
g/day
 TABLE 7:
Diagnosis
Primary glomerulonephritis
Secondary glomerulonephritis
Tubulointerstitial nephritis
Total
CHART 7:
 
 
 
17.24%
82 
 DISTRIBUTION OF RENAL DISEASES.
 Frequency 
 
46 
 
10 
 
2 
 
58 
 
 DISTRIBUTION OF RENAL DISEASES
 
79.31%
3.45%
Primary glomerulonephritis
Secondary glomerulonephritis
Tubulointerstitial nephritis
 
Percent 
79.31 
17.24 
3.45 
100.0 
. 
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TABLE 8: DISTRIBUTION OF CASES BASED ON 
DIAGNOSIS 
Final diagnosis Frequency Percent 
A.Primary glomerulonephritis (N=46) 79.31 
Diffuse proliferative glomerulonephritis 13 28.26 
Membranoproliferative glomerulonephritis 8 17.39 
Focal segmental glomerulosclerosis 7 15.22 
Membranous nephropathy 5 10.87 
Minimal change disease 5 10.87 
Ig A Nephropathy 2 4.35 
C1q Nephropathy 2 4.35 
Mesangioproliferative glomerulonephritis 2 4.35 
Chronic glomerulonephritis 1 2.17 
Sclerosing glomerulonephritis 1 2.17 
B.Secondary glomerulonephritis (N=10) 17.24 
Lupus nephritis 7 70 
Hypertension glomerulopathy 2 20 
Myeloma cast nephropathy 1 10 
C.Tubular interstitial disease (N=2) 3.45 
Acute tubular necrosis 2 100.0 
Total (N=58) 100.0 
 Of the 58 patients
constituted highest numbe
followed by membranoproliferative glomerulonephritis accounting for 
17.39% (8cases) overall 
of 10 secondary glomerulonephritis cases, Lupus nephritis was the most 
common lesion noted constituting 70% (7 cases)
females.  
CHART 8
DIAGNOSIS (PRIMARY GLOMERULONEPHRITIS) 
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, diffuse proliferative glomerulonephritis 
r of cases  accounting for 28.26%  (13
and also among primary glomerulonephritis. Out 
 and all of them were 
: DISTRIBUTION OF CASES BASED ON 
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28.26
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4.35
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 CHART 9: DISTRIBUTION OF CASES BASED ON DIAGNOSIS 
(SECONDARY GLOMERULONEPHRIT
 
Out of 10 secondary glomerulonephritis cases, Lupus nephritis was 
the most common lesion noted constituting 70% (7 cases) and all of them 
were females.  
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TABLE 9: SPECIAL STAINS FINDINGS 
Diagnosis Stains performed Findings 
Focal segmental 
glomerulosclerosis 
(n=7) 
A. PAS PAS-positive sclerosed part of 
glomeruli (n=7) 
B. JMS Wrinkled lines of GBM in 
sclerosed part of glomeruli 
(n=7) 
Membranous 
nephropathy (n=5) 
A. PAS Thickened GBM (n=5) 
B. JMS Spike formation in GBM 
(n=2) 
Thickened GBM (n=2) 
Moth eaten appearance of 
GBM (n=1) 
 
Membraproliferative 
glomerulonephritis 
(n=8) 
A. PAS Thickened GBM (n=8) 
B. JMS Double contour of GBM (n=3) 
Thickening of GBM (n=5) 
Myeloma cast 
nephropathy (n=1) 
A. PAS Weak Positive in tubular 
casts (n=1) 
B. JMS Negative in tubular casts 
(n=1) 
C. Congo red Negative in tubular casts 
(n=1) 
D. Masson 
Trichrome stain  
Casts appear green color 
(n=1) 
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Jones’s methanamine silver stains helped in typing/staging of 
membranous glomerulopathy and membrano proliferative 
glomerulonephritis.  
In 5 patients of MGN, spike formation was noted in GBM in 2 
patients which is seen in stage II MGN, thickening of GBM was noted in 
2 patients which is seen in stage IV MGN and moth eaten appearance of 
GBM was seen in 1 patient which is noted in stage III MGN.  
Out of 8 patients of MPGN, double contour of GBM was noted in 
3 patients which is seen type I MPGN and thickening of GBM was noted 
in 5 patients which is seen in type II MPGN. However, confirmatory 
typing/staging should be done when special stains findings are combined 
with electron microscopy findings of location of immune complex 
deposits. 
In a patient of myeloma cast nephropathy, tubular casts stained 
negative with Congo red which was used to differentiate it from amyloid 
deposits. Other stains like PAS, JMS and Masson trichrome were 
performed which stained weakly positive, negative and green color 
respectively.  
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TABLE 10: IMMUNOFLUORESCENCE  FINDINGS 
Immunofluorescence Frequency Percent 
Uniform granular staining of GBM 18 31.03 
Uniform granular staining of GBM and 
mesangial staining 
7 12.07 
Mesangial staining only 7 12.07 
Non-specific staining 10 17.24 
Negative 13 22.41 
Linear staining of glomerular basement 
membrane 
0 0 
No core 3 5.17 
Total 58 100.0 
 
Immunofluorescence studies showed positivity in 42 patients 
accounting for 72.41%. The predominant pattern was  granular staining in 
glomerular basement membrane which was noted in 18 patients 
(31.03%). 
 
 
 
 CHART 10:
 
A = Uniform granular staining of g
B = Uniform granular staining o
mesangial staining.
C = Mesangial staining
D = Non-specific staining
E= Negative. 
F = Linear staining 
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Granular GBM positivity was noted in 18 patients whose diagnoses 
included diffuse proliferative glomerulonephritis (5 patients), 
membranous nephropathy (5 patients), membranoproliferative 
glomerulonephritis (4 patients) and Lupus nephritis (4 patients). 
Non-specific staining in IF was noted in 10 patients whose 
diagnoses included focal segmental glomerulosclerosis (6 out of 7 cases), 
Acute tubular necrosis (1 out of 2 patients), sclerosing 
glomerulonephritis(1 patient), hypertensive glomerulopathy (1 out of 2 
patients) and myeloma cast nephropathy (1 patient).  
Negative staining was noted in 13 patients whose diagnoses 
included minimal change disease (all 5 patients), diffuse proliferative 
glomerulonephritis (4 out of 13 cases), focal segmental 
glomerulosclerosis (1 patient), hypertensive nephropathy (1 patient), 
acute tubular necrosis (1 patient) and chronic glomerulonephritis (1 
patient).  
No core was obtained for IF in two cases whose diagnoses included 
mesangioproliferative glomerulonephritis and diffuse proliferative 
glomerulonephritis.  
Out of 58 patients subjected for light microscopy and 
immunofluorescence studies, the immunofluorescence findings were of 
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diagnostic utility in 4 patients.  The final diagnosis was modified based 
on immunofluorescence findings in 1 patient.  
In two patients of mesangioproliferative glomerulonephritis, one of 
them showed intense mesangial staining of IgA and weak mesangial 
staining for C3 and the other patient showed intense mesangial staining of 
C1q. In one patient with light microscopic diagnosis of focal proliferative 
glomerulonephritis the IF finding was intense mesangial staining of IgA. 
In another patient with light microscopic diagnosis of focal segmental 
glomerulosclerosis, the IF findings showed intense mesangial staining of 
C1q. In these patients the diagnosis was given as IgA nephropathy and 
C1q nephropathy accordingly. Hence, the diagnostic utility of IF was 
noted in 4 cases (6.90%). 
In a case of minimal change disease, the diagnosis was modified to 
Lupus nephritis – class I after performing the immunofluorescence 
studies which showed C3 mesangial staining. Hence the IF studies helped 
in modification of the final diagnosis in 1 case (1.72%). 
 
 
 
 
 














  
 
 
 
 
DISCUSSION 
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DISCUSSION 
In the present study 58 renal biopsies were subjected to light 
microscopy and immunofluorescence studies to arrive at the final 
diagnosis. Special stains were done for all cases. The duration of the 
study was from October 2012 to June 2014.  
In the present study clinical, histomorphological features and 
immunofluorescence findings of various renal diseases were studied. The 
results obtained with the present study was compared with the other 
studies and discussed as follows.  
The parameters compared with the other studies are age distribution, 
gender distribution, frequency and most common primary 
glomerulonephritis, frequency and most common secondary 
glomerulonephritis, comparision of frequency of tubulointerstitial 
nephritis. 
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TABLE11: COMPARISION OF AGE DISTRIBUTION WITH 
OTHER STUDIES 
Authors Year Age range (years) 
A.R.Reshi et al[27] 2008 1 - 72 
Niang Adbu et al[45] 2003 5 – 60 
Ivan Rychlı´k et al[22] 2000 1 – 85 
Pierre Simon et al[19] 2002 10 - 80 
Present study 2014 9 - 57 
 
 
In the present study the age of the patients ranged from 9 to 57 
years which is in league with the study done by Pierre Simon et al. 
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TABLE 12: COMPARISION OF GENDER DISTRIBUTION WITH 
OTHER STUDIES 
Authors Year Male (%) Female (%) 
A.R.Reshi et al[27] 2008 66.2 33.8 
Riyad Said et al[54] 2000 53.4 46.6 
Ivan Rychlı´k et al[22] 2000 48.7 51.3 
Ikechi Okpechi et al[26] 2009 45.20 54.80 
Present study 2014 48.27 51.72 
 
In the present study, female predominance was noted with male to 
female ratio being 0.933:1. This is in league with the study done by 
Ikechi Okpechi et al and Ivan Rychlı´k et al.  
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TABLE13: COMPARISION OF FREQUENCY AND MOST 
COMMON PRIMARY GLOMERULONEPHRITIS WITH OTHER 
STUDIES 
Authors Year 
Primary 
lesions (%) Diagnosis 
A.R.Reshi et al[27] 2008 91.73 MCD 
Riyad Said et al[54] 2000 72.2 MPGN 
Nasar Yousuf Alwahaibi et al[29] 2010 69.1 FSGS 
Niang Adbu et al[45] 2003 69.5 FSGS 
Lt Col GU Deshpande et al[50] 2000 61.5 DPGN 
Ivan Rychlı´k et al[22] 2000 59.8 IgA Nephropathy 
Present study 2014 79.31 DPGN 
 
In the present study primary glomerular lesions constituted 79.31% 
of the renal diseases which was in concordance with the other studies and 
diffuse proliferative glomerulonephritis was the most common primary 
glomerular lesion noted which is in league with the study done by Lt Col 
GU Deshpande et al. The present study did not correlate with the other 
studies and it can be attributed to two reasons. Firstly, clinically 
suspected cases of membranous glomerulonephritis and minimal change 
disease presenting with nephrotic syndrome were not willing for the renal 
biopsy. Hence renal biopsy could not be attempted in such cases. 
Secondly, most of the patients were from low socioeconomic status with 
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high incidence of infections and poor public awareness regarding health 
care.[40] Hence, infective etiologic diagnosis was the most common lesion 
noted in the present study.  
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TABLE14: COMPARISION OF FREQUENCY AND MOST 
COMMON SECONDARY GLOMERULONEPHRITIS WITH 
OTHER STUDIES. 
Authors Year Secondary 
lesions (%) 
 
Diagnosis 
A.R.Reshi et al[27] 2008 8.28 Diabetic 
nephropathy 
Ahmed Al Arrayed et al[32] 2004 33.6 Lupus 
nephritis 
Nasar Yousuf Alwahaibi et al[29] 2010 30.9 Lupus 
nephritis 
Niang Adbu et al[45] 2003 23.5 Lupus 
nephritis 
Ivan Rychlı´k et al[22] 2000 25.4 Lupus 
nephritis 
Present study 2014 17.24 Lupus 
nephritis 
 
In the present study, secondary glomerular lesions constituted 
17.24% of the renal diseases which correlated with Niang Adbu et al and 
Ivan Rychlı´k et al and the most common secondary glomerular lesion 
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was Lupus nephritis which is in concordance with the studies done by 
Ahmed Al Arrayed et al, Niang Abdu et al, Nasar Yousuf Alwahaibi et al 
and Ivan Rychlı´k et al. All the patients of lupus nephritis were females (7 
patients). 
TABLE 15: COMPARISION OF FREQUENCY OF 
TUBULOINTERSTITIAL NEPHRITIS 
Authors Year TIN (%) 
Ivan Rychlı´k et al [22] 2000 4.4 
Patricia Malafronte et al [23] 2005 2.3 
Ikechi Okpechi et al [26] 2007 5.6 
Lei-shi li et al [20] 2002 3.43 
Present study 2014 3.45 
 
In the present study, tubulointerstitial nephritis cases constituted 
3.45% which is in concordance with all the above mentioned studies.  
 
 
 
  
 
 
 
 
SUMMARY AND 
CONCLUSION 
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SUMMARY 
• The present study is a cross sectional descriptive study. 
• The aim of this study is to determine the utility of direct 
immunofluorescence studies in renal diseases and also to study 
their various clinical presentations and histomorphological 
findings. 
• During the twenty months period of study from October 2012 to 
June 2014, 58 biopsies were received from the Department of 
Nephrology, Coimbatore Medical College and Hospital, 
Coimbatore.  
• The youngest patient was 9 years and the oldest patient was 57 
years.  
• The most common age group affected was 31 years to 40 years and 
the mean age at presentation was 33.03 years. The most common 
diagnosis in this age group was diffuse proliferative 
glomerulonephritis. 
• Females were slightly more affected than males and the male to 
female ratio was found to be 0.933:1. The most common 
glomerular lesion noted in males was diffuse proliferative 
glomerulonephritis (10 out of 28 cases) and in females was Lupus 
nephritis (7 out of 30 cases).  
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• 23 patients (39.66%) out of 58 presented with nephrotic range 
proteinuria whose diagnoses  included  diffuse proliferative 
glomerulonephritis (6 patients), Focal segmental 
glomerulosclerosis (4 patients), membranoproliferative 
glomerulonephritis (4 patients), membranous nephropathy (3 
patients), lupus nephritis (3 patients), minimal change disease (2 
patients) and chronic glomerulonephritis (1 patient). 
• 53 patients (91.38%)  had high blood urea nitrogen value more 
than 20.0 mg/dl. 
• 48 patients (82.76%) had high serum creatinine value more than 
1.2mg/dl.  
• Out of 58 biopsy specimens, 46 (79.31%)  showed primary 
glomerular lesions, 10 ( 17.24%) showed secondary glomerular 
lesion and 2 (3.45%) showed tubulointerstitial nephritis.  
• Diffuse proliferative glomerulonephritis was the most common 
primary glomerular lesion with a total of 13 out of 58 cases 
(22.41%). 
• Lupus nephritis was the most common secondary glomerular lesion 
with a total of 7 out of 58 cases (12.07%). 
• Jones’s methanamine silver stain along with PAS stain helped in 
typing/staging of membranous glomerulopathy and 
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membranoproliferative glomerulonephritis. Various changes in 
GBM like spike formation, thickening and moth eaten appearance 
of GBM was noted which is seen in MGN stage II, IV and III 
respectively. Double contour and thickening of GBM was noted 
which is seen in type I and II MPGN respectively. However, 
confirmation of  typing/staging could be done only when special 
stain findings are collaborated with electron microscopy findings 
which show location of immune complex deposits. 
• In Myeloma cast nephropathy, tubular casts stained negative with 
Congo red which was used to differentiate it from amyloid 
deposition. Other stains like PAS, JMS and Masson trichrome were 
performed which stained weakly positive, negative and green color 
respectively. Congo red stain should be performed in such patients 
to rule out amyloid deposition in myeloma cast nephropathy 
because it will help the clinician to look for amyloid deposition in 
other organs in such patients.  
• Immunofluorescence studies showed positivity in 42 patients 
accounting for 72.41%. The predominant pattern was granular 
glomerular basement membrane which was noted in 18 patients 
(31.03%). Immunofluorescence studies were negative in 13 cases 
(22.41%) and there was no core in 3 cases (5.17%).  
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• Granular GBM positivity was noted in 18 patients whose diagnoses 
included diffuse proliferative glomerulonephritis (5 patients), 
membranous nephropathy ( 5 patients), membranoproliferative 
glomerulonephritis (4 patients) and Lupus nephritis (4 patients). 
• Mesangial staining only was noted in 7 patients whose diagnoses 
included IgA nephropathy (2 patients), C1q nephropathy (2 
patients), Class I Lupus nephritis (1 patient), diffuse proliferative 
glomerulonephritis (2 patients). 
• Uniform granular staining of glomerular basement membrane and  
mesangial staining was noted in 7 patients whose diagnoses 
included membranoproliferative glomerulonephritis (3 patients), 
diffuse proliferative glomerulonephritis (2 patients) and lupus 
nephritis (2 patients).  
• Non-specific staining in IF was noted in 10 patients whose 
diagnoses included focal segmental glomerulosclerosis (6 out of 7 
cases), acute tubular necrosis (1 out of 2 patients), sclerosing 
glomerulonephritis (1 patient), hypertensive glomerulopathy (1 out 
of 2 patients) and myeloma cast nephropathy (1 patient).  
• Negative staining was noted in 13 patients whose diagnoses were 
minimal change disease (all 5 patients), diffuse proliferative 
glomerulonephritis (4 out of 13 patients), focal segmental 
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glomerulosclerosis (1 patient), hypertensive nephropathy (1 
patient), acute tubular necrosis (1 patient) and chronic 
glomerulonephritis (1 patient).  
• Negative staining was seen in 4 patients of DPGN which was 
subsequently attributed to contamination of phosphate buffer saline 
with formalin. This technical error prevented the positive staining 
in these cases.  
• No tissue core for IF in three cases whose diagnoses included 
mesangioproliferative glomerulonephritis (2 patients) and diffuse 
proliferative glomerulonephritis (1 patient). 
• Among two patients of mesangioproliferative glomerulonephritis, 
one of them showed intense mesangial staining of IgA and weak 
mesangial staining for C3 and the other patient showed intense 
mesangial staining of C1q. In one patient with light microscopic 
diagnosis of focal proliferative glomerulonephritis the IF finding 
was intense mesangial staining of IgA. In another patient with light 
microscopic diagnosis of focal segmental glomerulosclerosis, the 
IF findings showed intense mesangial staining of C1q. In these 
patients the diagnosis was given as IgA nephropathy and C1q 
nephropathy accordingly. Hence, the diagnostic utility of IF was 
noted in 4 cases (6.90%). 
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• In a case of minimal change disease, the diagnosis was modified to 
Lupus nephritis – class I after performing the immunofluorescence 
studies where the IF finding of mesangial C3  staining. Hence the 
IF studies helped in modification of the final diagnosis in 1 case 
(1.72%). 
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CONCLUSION 
The total number of 58 renal biopsies were subjected to light 
microscopy and immunofluorescence studies. Final diagnosis was arrived 
after carefully correlating with the clinical history, biochemical and 
serological parameters, histomorphology using various stains like 
haematoxylin and eosin, periodic acid Schiff and Jone’s methanamine 
silver stains, immunofluorescence study findings using a panel of markers 
(IgG, IgA, IgM, C3, C1q and Fibrinogen) in the biopsy tissue.  
The cases were grouped into primary and secondary glomerular 
diseases and tubulointerstitial nephritis. Out of total 58 cases, primary 
glomerulonephritis constituted 46 cases (79.31%), 10 cases (17.24%) 
were secondary glomerulonephritis and 2 cases (3.45%) were 
tubulointerstitial nephritis.  
Among the primary glomerulonephritis, diffuse proliferative 
glomerulonephritis was the most common lesion constituting 28.26% and 
the most common secondary glomerular lesion was Lupus nephritis 
constituting 70%. Since the exclusion criteria includes diabetic patients, 
the renal biopsy is attempted only when there are atypical features noted 
in diabetic patients like absence of diabetic retinopathy, rapid onset of 
nephrotic syndrome or proteinuria, low or rapid decrease in glomerular 
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filtration rate, presence of active urinary sediment and presence of signs 
and symptoms of other systemic diseases. So, the picture in the present 
study is different from other studies.   
Immunofluorescence studies helped in the modification of  the  
diagnosis in one case (Lupus nephritis class I)[79] after mesangial deposits 
for C3 was noted in immunofluorescence studies. Intense mesangial 
staining of IgA and C1q helped in making the diagnosis of IgA 
nephropathy and C1q nephropathy respectively. This shows the 
diagnostic value of IF studies and also helps the clinicians to plan the 
appropriate treatment modalities which differ from one diagnosis to 
another.[33]   
Use of special stains like Periodic acid Schiff and Jone’s 
methanamine silver stains helped to identify the extent of glomerular 
basement membrane involvement and  in typing/staging of MGN and 
MPGN that complemented the histomorphological findings. However, 
special stains in parallel with electron microscopy findings of location of 
immune complex deposits should be done for the confirmation of staging 
of MGN and typing of MPGN. This is helpful for the clinicians to plan a 
better therapeutic strategy in the nephrology patients.  
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In conclusion, the epidemiology of renal diseases differ from 
developed countries to developing countries. Developing country like 
ours has shown that the incidence of post infectious glomerulonephritis is 
still high compared to other glomerular lesions like membranous 
nephropathy and focal segmental glomerulosclerosis which is more 
common in developed countries.[15,21,24,25] This can be attributed to the low 
socioeconomic status, prevalence of infections, lack of awareness 
regarding health care.[80]  
Immunofluorescence studies have complemented the clinical, 
histomorphological  findings in 58 patients including primary, secondary 
glomerular and tubulointerstitial diseases. However, it was even more of 
diagnostic importance in 5 patients including IgA nephropathy, C1q 
nephropathy and Lupus nephritis class I where a confident diagnosis 
could be rendered only because of availability of immunofluorescence 
studies. Hence, immunofluorescence studies when combined with 
histomorphologic findings by light microscopy, clinical, biochemical and 
serological markers can yield a better and precise diagnosis which can 
help in improved management of nephrology patients.  
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Further study: 
Additional markers like kappa and lambda etc, could be applied in 
cases of myeloma kidney diseases to give a better diagnosis which 
includes predominant type of light chain deposition.   
Electron microscopy facility, when made available would 
complement the histomorphology and immunofluorescence findings. 
Confirmation of IF findings with immunohistochemistry markers 
which could be stored for a longer period, might prove as another 
milestone in diagnosing renal diseases.[30] 
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Age/Sex IP/OP 
no 
Symptoms Bld Urea S. Cr 
24 
HR 
U.P 
Pr. Diag HPE. No HPE Diag IF no IF findings 
Final 
diagnosis 
1 33/F 33990 PE, O, HTN 37 2.1 1.1 MGN 1598/12 MCD 4/12 C3-MES CLASS I LN 
2 45/F 61860 FP,PE,O,F,HTN 42 1.7 5 NS 2761/12 MGN 17/12 IgG,C3-Gr GBM MGN 
3 20/F 64554 FP,PE,A,F 60 2.1 1.6 NS 2799/12 MGN 22/12  IgG, C3- Gr. GBM MGN 
4 39/F 66389 FP,HTN 51 1.9 3 NS 2889/12 MPGN 24/12 IgG,C3-MES+Gr GBM MPGN I 
5 9/M 66513 FP,PE,O,A 33 1 4 NS 2958/12 DPGN 25/12 IgG,C3-MES+Gr GBM PIGN 
6 35/F 66258 FP,PE,O 140 2.8 2.5 LN 3113/12 LN - IV 33/12 IgG,C3-MES+Gr GBM LN - IV 
7 26/M 27885 FP,O,H 40 1.6 3.1 ?AGN 3153/12 DPGN 35/12 NEG DPGN 
8 23/M 27912 PE,HTN 85 4.3 5 NS 3169/12 HTN N 36/12 NEG HTN N 
9 38/M 27912 PE,O 55 2.4 5 CRF 3184/12 DPGN 37/12 NEG DPGN 
10 22/M 73707 Fe,H,O 29 0.9 1.7 ?IgA N 3230/12 DPGN 38/12 IgG,C3-MES+Gr GBM PIGN  
11 55/M 76878 O.PE 75 7.1 3.2 CKD/MM 3353/12 DPGN  42/12 NEG DPGN  
12 46/F 922 O,PE,FP,H 49 1.3 4.2 NS 73/13 MPGN 3/13 IgG- Gr GBM MPGN I 
13 45/M 76162 PE,FP 164 12 2.7 ARF 123/13 MCD 4/13 NEG MCD 
14 48/F 2266 FP,PE 78 4.8 5 RF 137/13 MGN 6/13 IgG,C3- Gr GBM MGN 
15 25/M 2043 FP,PE,HTN 57 3.5 2.2 ARF 162/13 HTN N 7/13 Fi-GBM HTN N 
MASTER CHART 
  
16 44/F 2782 O 135 2.2 6.1 ?SLE?GN 198/13 LN  8/13 
IgG, IgA, IgM, C3, 
C1q- Gr GBMC3- 
MES  
LN 
17 19/M 28181 FP 35 2.2 5.2 NS 233/13 FSGS 12/13 NEG FSGS 
18 32/F 28332 Green cowdung poison 70 4 2.1 ARF 415/13 ATN 13/13 NEG ATN 
19 15/M 28365 Fe,H,Ab PAIN 34 1.2 0.76 ?AGN 416/13 MCD 14/13 NEG MCD 
20 38/M 2846 PE,HTN 282 12.3 1 CRF 538/12 MPGN 17/13 IgG- Gr GBM, C3-MES MPGN  
21 25/F 9934 PE,A 39 0.9 0.75 NS 544/13 MPGN 18/13 IgG, C3- Gr GBM + MES MPGN 
22 35/F 28543 PE,FP,HTN 80 1.8 3.7 LN 730/13 MCD 21/13 NEG MCD 
23 29/F 186053 PE,FP,A,HTN 33 0.9 0.2 NS 754/13 DPGN 22/13 IgG,C3-Gr GBM PIGN 
24 29/F 11731 PE,O,SR 25 1.8 3.3 ?LN 755/13 LN  23/13 IgG,IgA,IgM,C3,C1q-Gr GBM LN 
25 37/F 14284 PE,FP,O 72 2 5 LN 803/13 LN  24/13 IgG,IgA,IgM,C3,C1q-Gr GBM LN 
26 50/F 19351 PE,O 20 1.9 3.7 NS 892/13 ATN 26/13 IgG + in tubules Non-
specific ATN 
27 18/M 23998 PE,O,FP,HTN 42 2.2 5 NS 1139/13 MPGN 28/13 C3- Gr GBM MPGN 
28 19/M 24861 O,PE,FP 97 4.3 5 NS 1236/13 DPGN 30/13 IgG-Gr GBM PIGN 
29 16/M 26943 H,Fe,Arthralgia 20 0.8 1 ?IgA N 1301/13 MES Pr. GN 32/13 IgA, C3- MES IgA N 
30 35/F 28510 FP, Ab pain 115 6.9 5 LN 1371/13 LN-IV 34/13 IgG,IgA,IgM,C3, C1q- Gr GBM LN - IV 
31 15/M 28737 O,PE,FP,Ab Pain 80 4.1 5 ?HSP 1483/13 DPGN 36/13 IgG,C3,IgA- Gr GBM, IgA- Intense + in MES 
PIGN- IgA 
Dominant 
  
32 18/M 31566 FP,O,H 29 1.1 5 NS 1538/13 FSGS 37/13 
IgM,C3- Nonspecific 
staining in sclerosed 
glomeruli 
FSGS 
33 45/M 37220 O,H,FP,Fe 68 7.7 3 ?PSGN 1894/13 DPGN 41/13 No tissue DPGN 
34 14/F 42954 O,FP,PE 20 0.7 2 NS 2060/13 FSGS 44/13 IgM-MES, C3-Gr GBM FSGS 
35 31/F 47307 PE,FP 27 0.8 1.6 NS 2364/13 DPGN 49/13 C3-MES PIGN 
36 42/M 52107 FP,PE,A,HTN 29 2.1 5 NS 2558/13 MGN 54/13 IgG, C3- Gr GBM MGN 
37 20/M 54131 O,PE,FP,Ab Pain 34 1.6 5 NS 2645/13 MPGN 57/13 C3- MES + Gr GBM MPGN 
38 35/F 58129 O,FP,PE 30 1.4 5 NS 2907/13 MPGN 61/13 C3-Gr GBM MPGN 
39 39/M 64016 F,FP,PE 54 3.9 6.5 ?MGN 3285/13 DPGN 63/13 IgG,C3-Gr GBM PIGN 
40 50/M 61075 Anuria,O,FP,PE,A 57 4.9 5 CKD/MM 3296/13 CGN 64/13 NEG CGN 
41 16/F 64297 PE,FP 125 5.7 5 ?RPGN,        ?PSGN 3309/13 FSGS 65/13 
C3- Non-specific 
staining FSGS 
42 50/F 67958 O,PE,HTN 48 2.7 5 ?MGN 3366/13 FSGS 66/13 C3- Non-specific 
staining FSGS 
43 21/F 67958 O,PE,FP 20 1.6 3 ?FSGS 3430/13 MCD 70/13 NEG MCD 
44 57/M 69390 PE,FP 20 1.8 3 ?MGN 3432/13 MPGN 71/13 IgG- Gr GBM, C3-MES MPGN 
45 32/M 69651 O,PE,FP 32 4.8 3 NS, FSGS 3488/13 MCD 72/13 NEG MCD 
46 26/F 72184 PE 37 2 2 ?FSGS 3587/13 FSGS 74/13 
IgM, C3- Non-specific 
staining of sclerosed 
glomeruli 
FSGS 
  
47 45/F 68012 HTN, Ab Pain 59 6.4 3 Myeloma Kidney 3614/13 
Myeloma cast 
nephropathy 75/13 
IgA,IgM,C3- CastS 
and MES 
Myeloma cast 
nephropathy 
48 35/F 74185 O,PE,FP,Ab P,Fe 31 1.7 2 NS 3944/13 DPGN 80/13 C3-MES PIGN 
49 47/F 4642 O,PE,FP,HTN 157 6.9 2 CKD/MM 404/14 MES Pr. GN 81/13 No tissue MES Pr. GN 
50 40/M 11306 PE,FP 65 3.5 2 RPGN 674/14 FSGS 6/14 IgG-WeaK GrGBM, C1q- Intense MES C1q N 
51 18/F 11952 H 26 0.9 2.2 ?HSP 705/14 FOCAL PR. GN 7/14 IgA,C3- MES IgA N 
52 50/F 11000 O,PE,HTN 54 1.8 2.4 NS 704/14 LN - IV 8/14 IgG,IgM,C3,C1q - Gr GBM, Fi - thrombi LN 
53 45/M 21340 O,PE,FP 54 1.6 3.1 NS 1463/14 MGN 11/14 IgG-Gr GBM MGN 
54 22/M 25150 PE, Joint pain 47 3.5 3 RPGN 1527/14 Sclerosing GN 13/14 
IgM,C3- Nonspecific 
staining in sclerosed 
glomeruli 
Sclerosing GN 
55 35/M 21500 PE,O,FP 40 2.9 3 NS 1624/14 DPGN 14/14 NEG DPGN 
56 53/F 28967 PE 25 0.7 3 ?MGN 1681/14 MES Pr. GN 16/14 No tissue MES Pr. GN 
57 45/F  28986 PE 44 1.7 3 NS 1682/14 MES Pr. GN 15/14 IgG,C1q- MES C1q N 
58 20/M 38959 O,PE,FP 40 2.3 2.2 ?MCD/ ?FSGS 2241/14 FSGS 23/14 
IgM, C3- Non-specific 
staining of sclerosed 
glomeruli 
FSGS 
  
KEY TO MASTER CHART 
24 HR U.P  –  24 hours urinary protein (g/day) 
A  – Ascites 
ABD pain –  Abdominal Pain 
AGN   – Acute glomerulonephritis 
ARF  –  Acute Renal Failure 
ATN  –  Acute tubular necrosis 
Bld Urea  –  Blood urea (mg/dl) 
C1q   –  Complement 1q 
C1q N –  Complement 1q Nephropathy 
C3c  –  Complement 3 
CRF  –  Chronic Renal Failure 
DPGN –  Diffuse proliferative glomerulonephritis 
F  –  Female 
Fe  –  Fever 
Fi  –  Fibrinogen 
FP  –  Facial puffiness 
FSGS  – Focal segmental glomerulosclerosis 
GN   – glomerulonephritis 
Gr GBM  –  granular Glomerular Basement Membrane 
H   –  Hematuria 
  
HPE Diag  –  Histopathology Diagnosis 
HPE No.  –  histopathology number 
HSP   –  Henoch Schonlein Purpura 
HTN   –  Hypertension 
IF findings  –  immunofluorescence findings 
IF No  –  immunofluorescence number 
Ig A N  –  Ig A Nephropathy 
LN  –  Lupus Nephritis 
M  –  Male 
MCD  –  Minimal change disease 
MES  –  Mesangial 
MGN  –  Membranous glomerulonephritis 
MM  –  Multiple myeloma 
MPGN –  Membranoproliferative glomerulonephritis 
NS  –  Nephrotic Syndrome 
O  –  Oliguria 
PE  – Pedal edema 
PIGN  –  Post Infectious glomerulonephritis 
Pr  –  Proliferative 
Pr Diag –  Provisional diagnosis 
 
  
RF  –  Renal failure 
RPGN –  Rapidly progressive glomerulonephritis 
S. Cr  –  Serum creatinine(mg/dl) 
S. no  –  Serial number 
SLE  –  Systemic Lupus Erythematosus 
SR  –  Skin Rash 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
ANNEXURE - I 
 
  
ANNEXURE – I: 
PROFORMA 
S. NO         :                                            NAME                      : 
OP/IP NO:                                             AGE AND SEX        : 
DATE        :                                             DATE OF BIOPSY  : 
Presenting complaint    : 
Anuria   Facial puffiness   
Oliguria   Fever   
Hematuria   Abdominal pain   
Dysuria   Skin  rash   
Pedal edema   Joint pain   
Sore throat   Abdominal mass   
 
Treatment history if any: 
Past history                     : Diabetes mellitus - 
                                          Hypertension - 
                                          Kidney disease - 
                                          Other medical diseases if any –  
Family history                : Diabetes mellitus - 
                                          Hypertension - 
                                          Kidney disease - 
                                          Other medical diseases if any –  
Personal history              :  
INVESTIGATIONS        :  
Urine analysis – 24 hour urine protein – 
                           Urine albumin -  
  
                           RBCs - 
                           Pus cells - 
                           Deposits - 
                           Casts –  
Renal function tests – serum creatinine - 
                                    Blood urea – 
Liver function tests – total protein – 
                                   Serum albumin –  
                                   Serum globulin –  
                                  Albumin: globulin – 
Total cholesterol level – 
Chest X-ray – 
Abdominal ultrasound scan – 
C3 levels- 
C4 levels- 
ANA - 
ANCA – 
ASO titre –  
Hbs Ab – 
Hepatitis C virus- 
Histopathology report:  
Immunofluorescence report:  
Special stain report:  
Final diagnosis:  
  
 
 
 
 
ANNEXURE - II 
 
  
ANNEXURE - 2: LIST OF ABBREVIATIONS 
C3c   –  Complement 3 
C1q   –  Complement 1q 
DIF   –  Direct Immunofluorescence 
DNA  –  Deoxy Ribonucleic Acid 
DPGN –  Diffuse proliferative glomerulonephritis 
FSGS  –  Focal segmental glomerulosclerosis 
GBM  –  Glomerular Basement Membrane 
GFR  –  Glomerular Filtration Rate 
HSP  –  Henoch Schonlein Purpura 
Ig  –  Immunoglobulin 
JMS   –  Jone’s Methanamine Silver stain 
LN  –  Lupus Nephritis 
MCD  –  Minimal change disease 
MGN   –  Membranous glomerulonephritis 
MPGN  –  Membranoproliferative glomerulonephritis 
NS   –  Nephrotic Syndrome 
PAS   –  Periodic Acid Schiff 
PBS   –  Phosphate Buffer Saline 
PSGN –  Post Streptococcal glomerulonephritis 
RBC  –  Red Blood Cell 
  
RPGN –  Rapidly progressive glomerulonephritis 
SLE  –  Systemic Lupus Erythematosus 
WHO  –  World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
ANNEXURE – III 
 
  
ANNEXURE - 3: GLOSSARY OF TERMS USED TO DESCRIBE 
              HISTOLOGIC LESIONS IN GLOMERULI 
Focal Involving less than 50% of glomeruli 
Diffuse Involving 50% or more of glomeruli 
Segmental Involving part of a glomerular tuft 
Global Involving all of a glomerular tuft 
Mesangial 
hypercellularity 
4 or more nuclei in a peripheral mesangial 
segment 
Endocapillary 
hypercellularity 
Increased cellularity internal to the GBM 
composed of leucocytes, endothelial cells 
and/or mesangial cells. 
Extracapillary 
hypercellularity 
Increased cellularity in Bowman’s space, i.e. 
less than one layer of parietal or visceral 
epithelial cells, or monocytes / macrophages. 
Crescent Extracapillary hypercellularity other than the 
epithelial hyperplasia of a collapsing variant 
of FSGS 
Fibrinoid necrosis Lytic destruction of cells and matrix with 
deposition of acidophilic fibrin-rich material 
Sclerosis  Increased extracellular collagenous matrix 
that is expanding the mesangium, obliterating 
capillary lumens or forming adhesions to 
Bowman’s capsule 
Hyaline  Glassy acidophilic extracellular material 
Membranoproliferative Combined capillary wall thickening and 
mesangial or endocapillary hypercellularity 
  
Lobular(hypersegmented) Consolidated expansion of segments that are 
demarcated by intervening urinary space 
Mesangiolysis  
 
Detachment of the paramesangial GBM from 
the mesangial matrix or lysis of mesangial 
matrix. 
Spikes  Projections of glomerular basement 
membrane intervening between subepithelial 
deposits ( seen in membranous nephropathy) 
Subepithelial   
 
Between podocyte and glomerular basement 
membrane 
Subendothelial  
 
Between endothelial cell and glomerular 
basement membrane 
Wire loop  Thick, rigid appearance of the capillary loop 
because of massive subendothelial deposition 
Activity  Treatment-reversible lesions like cellular 
crescents, proliferation, necrosis, cellular 
infiltrate. 
Chronicity Irreversible lesions with treatment like 
fibrous crescents, tubular atrophy, interstitial 
fibrosis, sclerosis.  
Tram-track Double contour of glomerular basement 
membrane due to deposits and/ or 
circumferential interposition 
 
